<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Cell Cycle via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Cell Cycle' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Cell+Cycle&t=Cell+Cycle&s=Search&f=source]]></link>
        <lastBuildDate>Tue, 07 Feb 2012 08:48:52 +0100</lastBuildDate>
        <item>
            <title>Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.</title>
            <link>http://www.medworm.com/index.php?rid=5659097&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293493%26dopt%3DAbstract</link>
            <description>Authors: Basu A, Banerjee P, Pal S
    Abstract
    Comment on: Basu A, et al. PLoS One 2011; 6:e23919.
    PMID: 22293493 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659097</comments>
            <pubDate>Sun, 05 Feb 2012 07:06:27 +0100</pubDate>
            <guid isPermaLink="false">5659097</guid>        </item>
        <item>
            <title>The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.</title>
            <link>http://www.medworm.com/index.php?rid=5659096&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293494%26dopt%3DAbstract</link>
            <description>In conclusion, our studies show p53 as a determining factor for induction of apoptosis vs. polyploidy upon inhibition of Aurora A.
    PMID: 22293494 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659096</comments>
            <pubDate>Sun, 05 Feb 2012 07:06:17 +0100</pubDate>
            <guid isPermaLink="false">5659096</guid>        </item>
        <item>
            <title>Myb: Getting involved in EMT.</title>
            <link>http://www.medworm.com/index.php?rid=5659100&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293402%26dopt%3DAbstract</link>
            <description>Authors: Ramsay R
    Abstract
    Comment on: Cesi V, et al. Cell Cycle 2011; 10:4149-61.
    PMID: 22293402 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659100</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659100</guid>        </item>
        <item>
            <title>Letter from the Publisher.</title>
            <link>http://www.medworm.com/index.php?rid=5659099&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293403%26dopt%3DAbstract</link>
            <description>Authors: Landes RG
    PMID: 22293403 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659099</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659099</guid>        </item>
        <item>
            <title>Drosophila cyclinD/Cdk4 regulates mitochondrial biogenesis, aging and sensitizes animals to hypoxic stress.</title>
            <link>http://www.medworm.com/index.php?rid=5659098&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22293404%26dopt%3DAbstract</link>
            <description>Authors: Icreverzi A, de la Cruz A, Van Voorhies W, Edgar B
    Abstract
    Drosophila cyclinD (CycD) is the single fly ortholog of the mammalian cyclin D1 and promotes both cell cycle progression and cellular growth. However, little is known about how CycD promotes cell growth. We show here that CycD/Cdk4 hyperactivity leads to increased mitochondrial biogenesis (mitobiogenesis), mitochondrial mass, NRF-1 activity (Tfam transcript levels) and metabolic activity in Drosophila, whereas loss of CycD/Cdk4 activity has the opposite effects. Surprisingly, both CycD/Cdk4 addition and loss of function increase mitochondrial superoxide production and decrease lifespan, indicating that an imbalance in mitobiogenesis may lead to oxidative stress and aging. In addition, we provide multiple lines of ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5659098</comments>
            <pubDate>Wed, 01 Feb 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5659098</guid>        </item>
        <item>
            <title>Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model.</title>
            <link>http://www.medworm.com/index.php?rid=5640053&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22274398%26dopt%3DAbstract</link>
            <description>In this study, we demonstrated that the Salmonella typhimurium A1-R tumor-targeting strain can inhibit and eradicate human glioma in an orthotopic nude-mouse model. S. typhimurium A1-R was administered by injection through a craniotomy open-window or intravenously in nude mice. To establish the model, 2 x 105 U87-RFP human glioma cells were injected stereotactically into the mouse brain through the craniotomy open window. Two weeks after glioma-cell implantation, mice were treated with S. typhimurium A1-R [2 x 10 ( 7) CFU/200 μl intravenous injection (i.v.) or 1 x 10 ( 6) CFU/1 μl intracranial injection (i.c.)] once a week for 3 weeks. Brain tumors were observed by fluorescence imaging through the craniotomy open window over time. S. typhimurium A1-R, administered i.c., inhibited brain t...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640053</comments>
            <pubDate>Mon, 30 Jan 2012 08:36:30 +0100</pubDate>
            <guid isPermaLink="false">5640053</guid>        </item>
        <item>
            <title>Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas.</title>
            <link>http://www.medworm.com/index.php?rid=5640052&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22274399%26dopt%3DAbstract</link>
            <description>Authors: Lehman NL, O'Donnell JP, Whiteley LJ, Stapp RT, Lehman TD, Roszka KM, Schultz LR, Williams CJ, Mikkelsen T, Brown SL, Ecsedy JA, Poisson LM
    Abstract
    Aurora A is critical for mitosis and is overexpressed in several neoplasms. Its overexpression transforms cultured cells, and both its overexpression and knockdown cause genomic instability. In transgenic mice, Aurora A haploinsufficiency, not overexpression, leads to increased malignant tumor formation. Aurora A thus appears to have both tumor-promoting and tumor-suppressor functions. Here, we report that Aurora A protein, measured by quantitative protein gel blotting, is differentially expressed in major glioma types in lineage-specific patterns. Aurora A protein levels in WHO grade II oligodendrogliomas (n = 16) and grade I...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640052</comments>
            <pubDate>Mon, 30 Jan 2012 08:36:21 +0100</pubDate>
            <guid isPermaLink="false">5640052</guid>        </item>
        <item>
            <title>Pick your poison: The Ripoptosome, a cell death platform regulating apoptosis and necroptosis.</title>
            <link>http://www.medworm.com/index.php?rid=5640050&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22274400%26dopt%3DAbstract</link>
            <description>In this report, we extend our recent studies and further the notion that the stoichiometric balance between RIP1 and cIAPs is critical for Ripoptosome formation. Furthermore, we demonstrate the critical relevance of the balance of expression levels of short (cFLIPS) or viral (vFLIP) forms of FLIP and RIP3 kinase for the spontaneous execution of necroptosis whenever cIAPs are absent in the cells. Our study thus supports and extends the intriguing role of the Ripoptosome for the regulation of apoptosis and necroptosis.
    PMID: 22274400 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5640050</comments>
            <pubDate>Mon, 30 Jan 2012 08:36:11 +0100</pubDate>
            <guid isPermaLink="false">5640050</guid>        </item>
        <item>
            <title>mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.</title>
            <link>http://www.medworm.com/index.php?rid=5623120&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262166%26dopt%3DAbstract</link>
            <description>In this study, we tested mTorKIs against a large panel of colorectal cancer (CRC) cell lines, and found that mTorKIs displayed broader anti-CRC activity than rapamycin, including CRC cells with K-Ras or B-Raf mutations, suggesting that these mTorKIs are particularly useful for CRCs resistant to EGFR inhibitors. Unexpectedly, we found that 40% CRC cell lines were intrinsically drug resistant. Moreover, we discovered an mTO R-independent 4E‑ BP1 phosphorylation that was correlated with mTorKI resistance. Altogether, our findings provide compelling preclinical support for testing mTorKIs in human CRC clinical trials. They further reveal the existence of significant intrinsic mTorKI drug resistance in cancer cells and suggest that 4E-BP1 phosphorylation is a predictive biomarker for mTorKI s...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623120</comments>
            <pubDate>Tue, 24 Jan 2012 09:53:01 +0100</pubDate>
            <guid isPermaLink="false">5623120</guid>        </item>
        <item>
            <title>Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.</title>
            <link>http://www.medworm.com/index.php?rid=5623119&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262167%26dopt%3DAbstract</link>
            <description>Authors: Yang H, Zheng Z, Zhao L, Li Q, Liao D
    Abstract
    Successful viral replication entails elimination or bypass of host antiviral mechanisms. Here, we show that shRNA-mediated knockdown of murine double minute (Mdm2) and its paralog Mdm4 enhanced the expression of early and late viral gene products during adenovirus (HAdV) infection. Remarkably, whereas the expression of HAdV genes was low in p53-deficient mouse embryonic fibroblasts (p53KO MEFs), the HAdV early gene products were efficiently expressed in Mdm2/p53 double-knockout (DKO) and Mdm4/p53 DKO MEFs, and viral capsid proteins were produced in Mdm2/p53 DKO MEFs. Thus, Mdm2 and Mdm4 seem to have potent antiviral property. In cells infected with wt HAdV or a mutant virus lacking the E1B-55K gene (dl 1520), both Mdm2 and Mdm...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623119</comments>
            <pubDate>Tue, 24 Jan 2012 09:52:50 +0100</pubDate>
            <guid isPermaLink="false">5623119</guid>        </item>
        <item>
            <title>Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis.</title>
            <link>http://www.medworm.com/index.php?rid=5623118&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262168%26dopt%3DAbstract</link>
            <description>We report here the generation and characterization of SGO1-mutant mice and show that haploinsufficiency of SGO1 leads to enhanced colonic tumorigenesis. Complete disruption of SGO1 results in embryonic lethality, whereas SGO1 (+/-) mice are viable and fertile. Haploinsufficiency of SGO1 results in genomic instability manifested as missegregation of chromosomes and formation of extra centrosomal foci in both murine embryonic fibroblasts and adult bone marrow cells. Enhanced CIN observed in SGO1-deficient mice resulted in an increase in formation of aberrant crypt foci (ACF) and accelerated development of tumors after exposure to azoxymethane (AOM), a colon carcinogen. Together, these results suggest that haploinsufficiency of SGO1 causes enhanced CIN, colonic preneoplastic lesions and tumor...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623118</comments>
            <pubDate>Tue, 24 Jan 2012 09:52:38 +0100</pubDate>
            <guid isPermaLink="false">5623118</guid>        </item>
        <item>
            <title>Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.</title>
            <link>http://www.medworm.com/index.php?rid=5623117&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262169%26dopt%3DAbstract</link>
            <description>Authors: Walter G, Ruediger R
    Abstract
    Evidence that protein phosphatase 2A (PP2A) is a tumor suppressor in humans came from the discovery of mutations in the genes encoding the Aα and Aβ subunits of the PP2A trimeric holoenzymes, Aα-B-C and Aβ-B-C. One point mutation, Aα-E64D, was found in a human lung carcinoma. It renders Aα specifically defective in binding regulatory B' subunits. Recently, we reported a knock-in mouse expressing Aα-E64D and an Aα knockout mouse. The mutant mice showed a 50-60% increase in the incidence of lung cancer induced by benzopyrene. Importantly, PP2A's tumor suppressor activity depended on p53. These data provide the first direct evidence that PP2A is a tumor suppressor in mice. In addition, they suggest that PP2A is a tumor suppressor in human...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623117</comments>
            <pubDate>Tue, 24 Jan 2012 09:52:27 +0100</pubDate>
            <guid isPermaLink="false">5623117</guid>        </item>
        <item>
            <title>Direct interactions between intestinal immune cells and the diet.</title>
            <link>http://www.medworm.com/index.php?rid=5623116&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262170%26dopt%3DAbstract</link>
            <description>Authors: Veldhoen M
    PMID: 22262170 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623116</comments>
            <pubDate>Tue, 24 Jan 2012 09:52:16 +0100</pubDate>
            <guid isPermaLink="false">5623116</guid>        </item>
        <item>
            <title> p53 is not directly relevant to the response of Polo-like kinase 1 inhibitors.</title>
            <link>http://www.medworm.com/index.php?rid=5623115&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262171%26dopt%3DAbstract</link>
            <description>In this study, we demonstrate that there is no obvious different cytotoxic response between cancer cells with and without functional p53, including the isogenic colon cancer cell lines HCT116p53(+/+) and HCT116p53(-/-), breast cancer cell line MCF7, lung cancer cell line A549 and cervical carcinoma cell line HeLa, after treatment with either siRNA against Plk1, the kinase domain inhibitors BI 2536 and BI 6727 or the PBD inhibitor Poloxin. We suggest that the p53 status is not a predictor for the response of Plk1 inhibition, at least not directly. Yet, the long-term outcomes of losing p53, such as genome instability, could be associated with the cytotoxicity of Plk1 inhibition. Further studies are required to investigate whether other circumstances of cancer cells, such as DNA replication/d...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623115</comments>
            <pubDate>Tue, 24 Jan 2012 09:52:05 +0100</pubDate>
            <guid isPermaLink="false">5623115</guid>        </item>
        <item>
            <title>Spatial consequences of blocking mTOR/S6K:relevance for therapy.</title>
            <link>http://www.medworm.com/index.php?rid=5623094&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262172%26dopt%3DAbstract</link>
            <description>Authors: Rosner M, Schipany K, Hengstschläger M
    Abstract
    Comment on: Rosner M, et al. Amino Acids 2011; In press.
    PMID: 22262172 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623094</comments>
            <pubDate>Tue, 24 Jan 2012 09:51:53 +0100</pubDate>
            <guid isPermaLink="false">5623094</guid>        </item>
        <item>
            <title>The Janus face of OSM mediated cardiomyocyte dedifferentiation during cardiac repair and disease.</title>
            <link>http://www.medworm.com/index.php?rid=5623093&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262173%26dopt%3DAbstract</link>
            <description>Authors: Pöling J, Gajawada P, Lörchner H, Polyakowa V, Szibor M, Böttger T, Warnecke H, Kubin T, Braun T
    Abstract
    Dedifferentiation is a common phenomenon among plants but has only been found rarely in vertebrates where it is mostly associated with regenerative responses such as formation of blastemae in amphibians to initiate replacement of lost body parts. Relatively little attention has been paid to dedifferentiation processes in mammals although a decline of differentiated functions and acquisition of immature, &quot;embryonic&quot; properties is seen in various disease processes. Dedifferentiation of parenchymal cells in mammals might serve multiple purposes including (1) facilitation of tissue regeneration by generation of progenitor-like cells and (2) protection of cells from hypo...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623093</comments>
            <pubDate>Tue, 24 Jan 2012 09:51:42 +0100</pubDate>
            <guid isPermaLink="false">5623093</guid>        </item>
        <item>
            <title>Cdc6 is required for meiotic spindle assembly in Xenopus oocytes.</title>
            <link>http://www.medworm.com/index.php?rid=5623092&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262174%26dopt%3DAbstract</link>
            <description>Authors: Narasimhachar Y, Webster DR, Gard DL, Coué M
    Abstract
    During the maturation of Xenopus oocytes, Cdc6 expression is necessary to establish replication competence to support early embryonic DNA replication. However, Cdc6 is expressed before the completion of MI, at a time when its function as a replication factor is not required, suggesting additional roles for Cdc6 in meiosis. Confocal immunofluorescence microscopy revealed that Cdc6 protein was distributed around the spindle precursor at the time of germinal vesicle breakdown (GVBD), and localized to the margin of the nascent spindle early in prometaphase. Cdc6 subsequently localized to spindle poles in late prometaphase, where it remained until metaphase arrest. Microinjection of antisense oligonucleotides specific for C...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623092</comments>
            <pubDate>Tue, 24 Jan 2012 09:51:30 +0100</pubDate>
            <guid isPermaLink="false">5623092</guid>        </item>
        <item>
            <title>Cyclin G-associated kinase regulates protein phosphatase 2A by phosphorylation of its B'γ subunit.</title>
            <link>http://www.medworm.com/index.php?rid=5623085&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262175%26dopt%3DAbstract</link>
            <description>Authors: Naito Y, Shimizu H, Kasama T, Sato J, Tabara H, Okamoto A, Yabuta N, Nojima H
    Abstract
    Protein phosphatase 2A (PP 2A) bearing the B'γ (= B'α/B56γ1/PR61γ) subunit is recruited to dephosphorylation targets by cyclin G. We demonstrate here that cyclin G-associated kinase (GAK), a component of the GAK/B'γ/cyclin G complex, directly phosphorylates the B'γ-Thr104 residue and regulates PP 2A activity. Indeed, an anti-B'γ-pT104 antibody detected immunofluorescence signals at the chromosome and centrosome during mitosis; these signals were reduced by siRNAmediated GAK knockdown. After DNA damage by γ-irradiation, the chromosome signals formed foci that colocalized with a DNA double-strand break (DSB) marker H2AX-pS139 (γH2AX) and CHK2-pT68. Moreover, B'γ-pT104 enhanced PP...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623085</comments>
            <pubDate>Tue, 24 Jan 2012 09:51:19 +0100</pubDate>
            <guid isPermaLink="false">5623085</guid>        </item>
        <item>
            <title>Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells.</title>
            <link>http://www.medworm.com/index.php?rid=5623084&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262176%26dopt%3DAbstract</link>
            <description>Authors: Morgado-Palacin L, Llanos S, Serrano M
    Abstract
    Ribosome biogenesis is the most demanding energetic process in proliferating cells and it is emerging as a critical sensor of cellular homeostasis. Upon disturbance of ribosome biogenesis, specific free ribosomal proteins, most notably L11, bind and inhibit Mdm2, resulting in activation of the tumor suppressor p53. This pathway has been characterized in somatic and cancer cells, but its function in embryonic pluripotent cells has remained unexplored. Here, we show that treatment with low doses of Actinomycin D or depletion of ribosomal protein L37, two well-established inducers of ribosomal stress, activate p53 in an L11-dependent manner in mouse embryonic stem cells (ESCs) and in induced pluripotent stem cells (iPSCs). Activ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623084</comments>
            <pubDate>Tue, 24 Jan 2012 09:51:07 +0100</pubDate>
            <guid isPermaLink="false">5623084</guid>        </item>
        <item>
            <title>The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma.</title>
            <link>http://www.medworm.com/index.php?rid=5623079&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262177%26dopt%3DAbstract</link>
            <description>Authors: Liguori L, Andolfo I, De Antonellis P, Aglio V, di Dato V, Marino N, Ivan Orlotti N, De Martino D, Capasso M, Petrosino G, Schramm A, Navas L, Paolo Tonini G, Eggert A, Iolascon A, Zollo M
    Abstract
    Through microarray analyses, we identified the Mpped2 gene as differentially expressed in two neuroblastoma cell lines induced to differentiation with all-trans retinoic acid. Mpped2 codes for a new metallophosphodiesterase protein, the expression of which inhibits cell proliferation and soft agar colony formation in SH -SY5Y cells. This inhibition is concomitant to an increased proportion of the cells in G0/G1 phase and enhanced caspase 3 activation, effects not seen for the other phosphodiesterases. A Mpped2-null mutation (H67R) abrogates these functions, which indicates that ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623079</comments>
            <pubDate>Tue, 24 Jan 2012 09:50:55 +0100</pubDate>
            <guid isPermaLink="false">5623079</guid>        </item>
        <item>
            <title>Brg1 regulates the transcription of human papillomavirus type 18 E6 and E7 genes.</title>
            <link>http://www.medworm.com/index.php?rid=5623078&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262178%26dopt%3DAbstract</link>
            <description>Authors: He H, Luo Y
    Abstract
    Integrated high-risk human papillomavirus (HPV) DNA was frequently detected in the genomes of cervical carcinoma cells. The HPV E6 and E7 oncoproteins disrupt the functions of tumor suppressors p53 and Rb; thus, understanding the mechanism by which HPV E6 and E7 gene expression is regulated in cancer cells is highly relevant to cancer biology. Brg1 is a catalytic subunit of the SWI/SNF chromatin remodeling complexes that function in the transcriptional regulation of certain cellular genes. Here, we show that knockdown of Brg1 in HeLa cells leads to cell cycle arrest, p53 and Rb protein accumulation and, interestingly, downregulated expression of HPV18 E6 and E7 genes. Brg1 binds the HPV18 LCR in a JunB- and p300-dependent manner and is required for eff...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623078</comments>
            <pubDate>Tue, 24 Jan 2012 09:50:44 +0100</pubDate>
            <guid isPermaLink="false">5623078</guid>        </item>
        <item>
            <title>Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: Insights from zebrafish genetics.</title>
            <link>http://www.medworm.com/index.php?rid=5623077&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262179%26dopt%3DAbstract</link>
            <description>Authors: Ding Y, Sun X, Redfield M, Kushwaha S, Xu X
    Abstract
    Comment on: Ding Y, et al. Circ Res 2011; 109:658-69.
    PMID: 22262179 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623077</comments>
            <pubDate>Tue, 24 Jan 2012 09:50:32 +0100</pubDate>
            <guid isPermaLink="false">5623077</guid>        </item>
        <item>
            <title>GSK3β regulates Bcl2L12 and Bcl2L12A anti-apoptosis signaling in glioblastoma and is inhibited by LiCl.</title>
            <link>http://www.medworm.com/index.php?rid=5623076&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262180%26dopt%3DAbstract</link>
            <description>In this study, we showed that BCL2L12 and BCL2L12A were overexpressed in glioblastoma multiforme (GBM). Large-scale yeast two-hybrid screening showed that BCL2L12 was a GSK3b binding partner in a testis cDNA library. Our data demonstrated that GSK3b interacts with BCL2L12 but not BCL2L12A, whose C terminus lacks a binding region. We found that a BCL2L12 153-191 fragment located outside of the C-terminal BH2 motif is responsible for GSK3b binding. In contrast, no interaction was detected between BCL2L12A and GSK3b. In vitro kinase and l-phosphatase assays showed that GSK3b phosphorylates BCL2L12 at S156, while this site is absent on BCL2L12A. Moreover, our data also showed that the BCL2L12 153-191 fragment directly interrupted GSK3bmediated Tau phosphorylation in a dose-dependent manner. Ec...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623076</comments>
            <pubDate>Tue, 24 Jan 2012 09:50:21 +0100</pubDate>
            <guid isPermaLink="false">5623076</guid>        </item>
        <item>
            <title>Murine models of ovarian cancer for preclinical testing of targeted therapeutics: Has their time arrived?</title>
            <link>http://www.medworm.com/index.php?rid=5623075&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262181%26dopt%3DAbstract</link>
            <description>Authors: Cho KR
    Abstract
    Comment on: Wu R, et al. Clin Cancer Res 2011; 17:7359-72.
    PMID: 22262181 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623075</comments>
            <pubDate>Tue, 24 Jan 2012 09:50:11 +0100</pubDate>
            <guid isPermaLink="false">5623075</guid>        </item>
        <item>
            <title>Autoregulation of kinase dephosphorylation by ATP binding in AGC protein kinases.</title>
            <link>http://www.medworm.com/index.php?rid=5623073&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262182%26dopt%3DAbstract</link>
            <description>Authors: Chan TO, Pascal J, Armen R, Rodeck U
    Abstract
    AGC kinases, including the three Akt (protein kinase B) isoforms, protein kinase A (PKA) and all protein kinase C (PKC) isoforms, require activation loop phosphorylation (threonine 308 in Akt1) as well as phosphorylation of a C-terminal residue (serine 473 in Akt1) for catalytic activity and phosphorylation of downstream targets. Conversely, phosphatases reverse these phosphorylations. Virtually all cellular processes are affected by AGC kinases, a circumstance that has led to intense scrutiny of the molecular mechanisms that regulate phosphorylation of these kinases. Here, we review a new layer of control of phosphorylation in Akt, PKA and PKC pointing to ATP binding pocket occupancy as a means to decelerate dephosphorylation ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623073</comments>
            <pubDate>Tue, 24 Jan 2012 09:49:59 +0100</pubDate>
            <guid isPermaLink="false">5623073</guid>        </item>
        <item>
            <title>TRIM8 modulates p53 activity to dictate cell cycle arrest.</title>
            <link>http://www.medworm.com/index.php?rid=5623072&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262183%26dopt%3DAbstract</link>
            <description>We described here that the human TRIM8 protein, a member of the TRIM family, is a new modulator of the p53-mediated tumor suppression mechanism. We showed that under stress conditions, such as UV exposure, p53 induced the expression of TRIM8, which in turn stabilized p53 leading to cell cycle arrest and reduction of cell proliferation through enhancement of CDKN1A (p21) and GADD45 expression. TRIM8 silencing reduced the capacity of p53 to activate genes involved in cell cycle arrest and DNA repair, in response to cellular stress. Concurrently, TRIM8 overexpression induced the degradation of the MDM2 protein, the principal regulator of p53 stability. Co-immunoprecipitation experiments showed that TRIM8 physically interacted with p53, impairing its interaction with MDM2. Altogether, our resu...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623072</comments>
            <pubDate>Tue, 24 Jan 2012 09:49:48 +0100</pubDate>
            <guid isPermaLink="false">5623072</guid>        </item>
        <item>
            <title>Does Δ133p53 isoform trigger inflammation and autoimmunity?</title>
            <link>http://www.medworm.com/index.php?rid=5623071&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262184%26dopt%3DAbstract</link>
            <description>Authors: Campbell H, Slatter T, Jeffs A, Mehta R, Rubio C, Baird M, Braithwaite A
    Abstract
    Autoimmune diseases are characterized by the immune system mounting a response against self. The exact etiology of autoimmune diseases and autoimmunity remain unclear. Here, we demonstrate that Δ133p53, an isoform of the tumor suppressor protein p53, is involved in the development of autoimmunity. We have previously generated a mouse model of Δ133p53 (Δ122p53). Δ122p53 mice develop an autoimmune/ inflammation-like phenotype that includes the production of autoantibodies, elevated levels of pro-inflammatory cytokines and lymphocyte aggregations in various organs. Microarray analysis reveals that expression of Δ122p53 induces a number of pro-inflammatory genes, including the STAT1 pathway ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623071</comments>
            <pubDate>Tue, 24 Jan 2012 09:49:36 +0100</pubDate>
            <guid isPermaLink="false">5623071</guid>        </item>
        <item>
            <title>Linking hematopoietic regeneration to developmental signaling pathways: A story of BMP and Wnt.</title>
            <link>http://www.medworm.com/index.php?rid=5623070&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262185%26dopt%3DAbstract</link>
            <description>Authors: Bowman TV, Trompouki E, Zon LI
    Abstract
    Comment on: Trompouki E, et al. Cell 2011; 147:577-89.
    PMID: 22262185 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623070</comments>
            <pubDate>Tue, 24 Jan 2012 09:49:25 +0100</pubDate>
            <guid isPermaLink="false">5623070</guid>        </item>
        <item>
            <title>MicroRNA/mRNA regulatory networks in the control of skin development and regeneration.</title>
            <link>http://www.medworm.com/index.php?rid=5623069&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262186%26dopt%3DAbstract</link>
            <description>Authors: Botchkareva N
    Abstract
    Skin development, postnatal growth and regeneration are governed by complex and well-balanced programs of gene activation and silencing. The crosstalk between small non-coding microRNAs (miRNAs) and mRNAs is highly important for steadiness of signal transduction and transcriptional activities as well as for maintenance of homeostasis in many organs, including the skin. Recent data demonstrated that the expression of many genes, including cell type-specific master transcription regulators implicated in the control of skin development and homeostasis, is regulated by miRNAs. In addition, individual miRNAs could mediate the effects of these signaling pathways through being their downstream components. In turn, the expression of a major constituent of th...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623069</comments>
            <pubDate>Tue, 24 Jan 2012 09:49:14 +0100</pubDate>
            <guid isPermaLink="false">5623069</guid>        </item>
        <item>
            <title>Cell-autonomous hepatic circadian clock regulates polyamine synthesis.</title>
            <link>http://www.medworm.com/index.php?rid=5623068&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262187%26dopt%3DAbstract</link>
            <description>Authors: Atwood A, Kay SA
    Abstract
    Comment on: Atwood A, et al. Proc Natl Acad Sci U S A 2011; 108:18560-5.
    PMID: 22262187 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623068</comments>
            <pubDate>Tue, 24 Jan 2012 09:49:02 +0100</pubDate>
            <guid isPermaLink="false">5623068</guid>        </item>
        <item>
            <title>BRAF mutation: A double-edged sword in epigenetic alterations?</title>
            <link>http://www.medworm.com/index.php?rid=5623067&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262188%26dopt%3DAbstract</link>
            <description>Authors: Xu X
    Abstract
    Comment on: Hou P, et al. Cell Cycle 2012; 11:286-95.
    PMID: 22262188 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623067</comments>
            <pubDate>Tue, 24 Jan 2012 09:48:50 +0100</pubDate>
            <guid isPermaLink="false">5623067</guid>        </item>
        <item>
            <title>Polo-like kinase 2: A new exploitable target to undermine mutant p53 dependent chemoresistance.</title>
            <link>http://www.medworm.com/index.php?rid=5623066&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262189%26dopt%3DAbstract</link>
            <description>Authors: Napoli M, Girardini JE, Del Sal G
    Abstract
    Comment on: Valenti F, et al. Cell Cycle 2011; 10:4330-40.
    PMID: 22262189 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623066</comments>
            <pubDate>Tue, 24 Jan 2012 09:48:39 +0100</pubDate>
            <guid isPermaLink="false">5623066</guid>        </item>
        <item>
            <title>Chemotherapy-induced p53-dependent and -independent DNA damage responses are enhanced by poly(ADP-ribose) polymerase (PARP) inhibition in BRCA-proficient cancer cells.</title>
            <link>http://www.medworm.com/index.php?rid=5623065&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262190%26dopt%3DAbstract</link>
            <description>Authors: Johnson N, Shapiro GI
    Abstract
    Comment on: Nguyen D, et al. Cell Cycle 2011; 10:4074-82.
    PMID: 22262190 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623065</comments>
            <pubDate>Tue, 24 Jan 2012 09:48:28 +0100</pubDate>
            <guid isPermaLink="false">5623065</guid>        </item>
        <item>
            <title>Autophagy-dependent NFκB regulation.</title>
            <link>http://www.medworm.com/index.php?rid=5623060&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262191%26dopt%3DAbstract</link>
            <description>Authors: Cianfanelli V, Cecconi F
    Abstract
    Comment on: Criollo A, et al. Cell Cycle 2012; 11:194-9.
    PMID: 22262191 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623060</comments>
            <pubDate>Tue, 24 Jan 2012 09:48:20 +0100</pubDate>
            <guid isPermaLink="false">5623060</guid>        </item>
        <item>
            <title>The proteasome activator PA28γ is a novel component of the DNA double-strand break response network.</title>
            <link>http://www.medworm.com/index.php?rid=5623059&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22262192%26dopt%3DAbstract</link>
            <description>Authors: Ben-Aroya S
    Abstract
    Comment on: Levy-Barda A, et al. Cell Cycle 2011; 10:4300-10.
    PMID: 22262192 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623059</comments>
            <pubDate>Tue, 24 Jan 2012 09:48:10 +0100</pubDate>
            <guid isPermaLink="false">5623059</guid>        </item>
        <item>
            <title>The lesser known story of X chromosome reactivation: a closer look into the reprogramming of the inactive X chromosome.</title>
            <link>http://www.medworm.com/index.php?rid=5623122&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22234239%26dopt%3DAbstract</link>
            <description>Authors: Hysolli E, Tanaka Y, Kim KY, Jung YW, Park IH
    Abstract
    X-chromosome inactivation (XCI) is an important mechanism employed by mammalian XX female cells to level X-linked gene expression with that of male XY cells. XCI occurs early in development as the pluripotent cells of the inner cell mass (ICM) in blastocysts successively differentiate into cells of all three germ layers. X-chromosome reactivation (XCR), the reversal of XCI, is critical for germ cell formation as a mechanism to diversify the X-chromosome gene pool. Here we review the characterization of XCR, and further explore its natural occurrence during development and the in vitro models of cellular reprogramming. We also review the key regulators involved in XCI for their role in suppressing the active histone mar...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623122</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623122</guid>        </item>
        <item>
            <title>Is cancer a metabolic rebellion against host aging? In the quest for immortality, tumor cells try to save themselves by boosting mitochondrial metabolism.</title>
            <link>http://www.medworm.com/index.php?rid=5623121&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22234241%26dopt%3DAbstract</link>
            <description>Authors: Ertel A, Tsirigos A, Whitaker-Menezes D, Birbe RC, Pavlides S, Martinez-Outschoorn UE, Pestell RG, Howell A, Sotgia F, Lisanti MP
    Abstract
    Aging drives large systemic reductions in oxidative mitochondrial function, shifting the entire body metabolically towards aerobic glycolysis, a.k.a, the Warburg effect. Aging is also one of the most significant risk factors for the development of human cancers, including breast tumors. How are these two findings connected? One simplistic idea is that cancer cells rebel against the aging process by increasing their capacity for oxidative mitochondrial metabolism (OXPHOS). Then, local and systemic aerobic glycolysis in the aging host would provide energy-rich mitochondrial fuels (such as L-lactate and ketones) to directly &quot;fuel&quot; tumor ce...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5623121</comments>
            <pubDate>Sun, 15 Jan 2012 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">5623121</guid>        </item>
        <item>
            <title>What makes the engine hum: Rad6, a cell cycle supercharger.</title>
            <link>http://www.medworm.com/index.php?rid=5578509&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214660%26dopt%3DAbstract</link>
            <description>Authors: Enserink JM, Kolodner RD
    Abstract
    Deregulated CDK activity drives cell proliferation of the majority of human tumors, making CDKs highly relevant research subjects. Cdc28 controls cell cycle progression in the budding yeast Saccharomyces cerevisiae, but the identity of many genes that function in conjunction with CDC28 to regulate the cell cycle and cell viability remains obscure. In a recent study, we used a chemical-genetic screen to identify the genetic network of CDC28. Through this analysis, we discovered that the Rad6-Bre1 pathway functions in this network and links ubiquitin levels to cell cycle progression by increasing transcription of cyclin genes. Thus, Rad6 boosts the activity of the cell cycle machinery.
    PMID: 22214660 [PubMed - as supplied by publisher] (...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578509</comments>
            <pubDate>Wed, 11 Jan 2012 16:03:06 +0100</pubDate>
            <guid isPermaLink="false">5578509</guid>        </item>
        <item>
            <title>Deconvoluting mTOR biology.</title>
            <link>http://www.medworm.com/index.php?rid=5578508&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214661%26dopt%3DAbstract</link>
            <description>Authors: Weber JD, Gutmann DH
    Abstract
    In metazoans, TOR is an essential protein that functions as a master regulator of cellular growth and proliferation. Over the past decade, there has been an explosion of information about this critical master kinase, ranging from the composition of the TOR protein complex to its ability to act as an integrator of numerous extracellular signals. Unfortunately, this plethora of information has also raised numerous questions regarding TOR function. Currently, the prevailing view is that mammalian TOR (mTOR) exists in at least two molecular complexes, mTORC1 and mTORC2, which are largely defined by the presence of either RAPTOR or RICTOR. However, additional co-factors have been identified for each complex, and their importance in mediating mTOR s...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578508</comments>
            <pubDate>Wed, 11 Jan 2012 16:02:58 +0100</pubDate>
            <guid isPermaLink="false">5578508</guid>        </item>
        <item>
            <title>The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation leading to G 1 arrest.</title>
            <link>http://www.medworm.com/index.php?rid=5578507&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214662%26dopt%3DAbstract</link>
            <description>Authors: Bennett R, Pan Y, Christian J, Hui T, May WS
    Abstract
    Cellular stresses, including growth factor deprivation, inflammatory cytokines or viral infection promote RAX/PACTdependent activation of the double-stranded RNA-dependent protein kinase, PKR, to phosphorylate eIF2α, resulting in translation inhibition and apoptosis. In addition, PKR has been reported to regulate p53, STAT1 and NFκB. Here, we report that RAX/PACT interacts with the SUMO E2 ligase Ubc9 to stimulate p53-Ubc9 association and reversible p53 sumoylation on lysine 386. In addition, expression of RAX/PACT in a variety of cell lines promotes p53 stability and activity to increase p53 target gene expression. Significantly, while the expression of RAX/PACT, PKR or p53 alone has little effect on the cell cycle o...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578507</comments>
            <pubDate>Wed, 11 Jan 2012 16:02:49 +0100</pubDate>
            <guid isPermaLink="false">5578507</guid>        </item>
        <item>
            <title>Mutant p53 subverts PLK2 function in a novel, reinforced loop of corruption.</title>
            <link>http://www.medworm.com/index.php?rid=5578506&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214663%26dopt%3DAbstract</link>
            <description>Authors: Haupt S, Haupt Y
    Abstract
    Comment on: Valenti F, et al. Cell Cycle 2011; 10:4330-40.
    PMID: 22214663 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578506</comments>
            <pubDate>Wed, 11 Jan 2012 16:02:41 +0100</pubDate>
            <guid isPermaLink="false">5578506</guid>        </item>
        <item>
            <title>Providing the TORC for cell cycle progression in neoplastic mast cells.</title>
            <link>http://www.medworm.com/index.php?rid=5578505&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214664%26dopt%3DAbstract</link>
            <description>Authors: Smrž D, Wilson TM, Metcalfe DD, Gilfillan AM
    Abstract
    Comment on: Smrž D, et al. Blood 2011; 118:6803-13.
    PMID: 22214664 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578505</comments>
            <pubDate>Wed, 11 Jan 2012 16:02:32 +0100</pubDate>
            <guid isPermaLink="false">5578505</guid>        </item>
        <item>
            <title>A new chronological survival assay in mammalian cell culture.</title>
            <link>http://www.medworm.com/index.php?rid=5578504&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214665%26dopt%3DAbstract</link>
            <description>Authors: Kaeberlein M, Kennedy BK
    PMID: 22214665 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578504</comments>
            <pubDate>Wed, 11 Jan 2012 16:02:23 +0100</pubDate>
            <guid isPermaLink="false">5578504</guid>        </item>
        <item>
            <title>The shark in us: Learning about the evolution of the p53 regulatory circuit.</title>
            <link>http://www.medworm.com/index.php?rid=5578503&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214666%26dopt%3DAbstract</link>
            <description>Authors: Rutkowski R, Gartner A
    Abstract
    Comment on: Lane DP, et al. Cell Cycle 2011; 10:4272-9.
    PMID: 22214666 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578503</comments>
            <pubDate>Wed, 11 Jan 2012 16:02:15 +0100</pubDate>
            <guid isPermaLink="false">5578503</guid>        </item>
        <item>
            <title>miR-34 and SNAIL: Another double-negative feedback loop controlling cellular plasticity/EMT governed by p53.</title>
            <link>http://www.medworm.com/index.php?rid=5578502&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214667%26dopt%3DAbstract</link>
            <description>Authors: Brabletz T
    Abstract
    Comment on: Siemens H, et al. Cell Cycle 2011; 10:4256-71.
    PMID: 22214667 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578502</comments>
            <pubDate>Wed, 11 Jan 2012 16:02:05 +0100</pubDate>
            <guid isPermaLink="false">5578502</guid>        </item>
        <item>
            <title>The evolution of the p53 family of genes.</title>
            <link>http://www.medworm.com/index.php?rid=5578501&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214668%26dopt%3DAbstract</link>
            <description>Authors: Levine AJ
    Abstract
    Comment on: Lane DP, et al. Cell Cycle 2011; 10:4272-9.
    PMID: 22214668 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578501</comments>
            <pubDate>Wed, 11 Jan 2012 16:01:56 +0100</pubDate>
            <guid isPermaLink="false">5578501</guid>        </item>
        <item>
            <title>Bipolar disorder: Kinesin-12 to the rescue.</title>
            <link>http://www.medworm.com/index.php?rid=5578500&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214669%26dopt%3DAbstract</link>
            <description>Authors: Dumont J
    Abstract
    Comment on: Florian S, et al. Cell Cycle 2011; 10:3533-44.
    PMID: 22214669 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578500</comments>
            <pubDate>Wed, 11 Jan 2012 16:01:46 +0100</pubDate>
            <guid isPermaLink="false">5578500</guid>        </item>
        <item>
            <title>A functional cooperativity between Aurora A kinase and LIM kinase1: Implication in the mitotic process.</title>
            <link>http://www.medworm.com/index.php?rid=5578499&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214762%26dopt%3DAbstract</link>
            <description>Authors: Ritchey L, Ottman R, Roumanos M, Chakrabarti R
    Abstract
    Aurora kinase A (Aur-A), a mitotic kinase, regulates initiation of mitosis through centrosome separation and proper assembly of bipolar spindles. LIM kinase 1 (LIMK1), a modulator of actin and microtubule dynamics, is involved in the mitotic process through inactivating phosphorylation of cofilin. Phosphorylated LIMK1 is recruited to the centrosomes during early prophase, where it colocalizes with γ-tubulin. Here, we report a novel functional cooperativity between Aur-A and LIMK1 through mutual phosphorylation. LIMK1 is recruited to the centrosomes during early prophase and then to the spindle poles, where it colocalizes with Aur-A. Aur-A physically associates with LIMK1 and activates it through phosphorylation, whic...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578499</comments>
            <pubDate>Wed, 11 Jan 2012 16:01:35 +0100</pubDate>
            <guid isPermaLink="false">5578499</guid>        </item>
        <item>
            <title>Monitoring APC/C activity in the presence of chromosomal misalignment in unperturbed cell populations.</title>
            <link>http://www.medworm.com/index.php?rid=5578498&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214763%26dopt%3DAbstract</link>
            <description>Authors: Schnerch D, Follo M, Krohs J, Felthaus J, Engelhardt M, Wäsch R
    Abstract
    Chromosome segregation is under strict control of the spindle assembly checkpoint (SAC). The SAC regulates anaphase-promoting complex/cyclosome (APC/C)-dependent proteolysis of securin and cyclin B. Unattached or misaligned chromosomes trigger SAC-mediated mitotic delay by stabilizing securin and cyclin B due to inhibition of APC/C until the problem is solved. Here we present a hitherto unavailable model facilitating the simultaneous depiction of chromosome movements and pulse-chased cyclin B proteolysis in every single cell within a cell population. During chromosome misalignment, we observed slow cyclin B degradation, which changed to fast degradation once the SAC was satisfied, initiating chromoso...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578498</comments>
            <pubDate>Wed, 11 Jan 2012 16:01:25 +0100</pubDate>
            <guid isPermaLink="false">5578498</guid>        </item>
        <item>
            <title>Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5578497&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214764%26dopt%3DAbstract</link>
            <description>In this study, we demonstrate that ZBP‑89 is essentially required in HDACi-mediated p21 upregulation in hepetocellular carcinoma (HCC). Overexpression of ZBP-89 protein enhanced the lethal effectiveness of Trichostatin A (TSA). p53 mutant p53 (G245D) , but not p53 (R249S) , directly bound to ZBP-89 and prevented its translocation from cytoplasm to nucleus. Furthermore, p53 (G245D) was shown to have a similar pattern of subcellular localization to ZBP-89 in tissues of HCC patients in Hong Kong. Functionally, the cytoplasmic accumulation of ZBP-89 by p53 (G245D) significantly abrogated the induction of p21 caused by sodium butyrate (NaB) treatment and protected cells from TSA-induced death. The activations of several apoptotic proteins, such as Bid and PARP, were involved in p53 (G245D) -m...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578497</comments>
            <pubDate>Wed, 11 Jan 2012 16:01:14 +0100</pubDate>
            <guid isPermaLink="false">5578497</guid>        </item>
        <item>
            <title>Aging reverses the role of the transient receptor potential vanilloid-1 channel in systemic inflammation from anti-inflammatory to proinflammatory.</title>
            <link>http://www.medworm.com/index.php?rid=5578496&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214765%26dopt%3DAbstract</link>
            <description>Authors: Wanner SP, Garami A, Pakai E, Oliveira DL, Gavva NR, Coimbra CC, Romanovsky AA
    Abstract
    Studies in young rodents have shown that the transient receptor potential vanilloid-1 (TRPV1) channel plays a suppressive role in the systemic inflammatory response syndrome (SIRS) by inhibiting production of tumor necrosis factor (TNF)α and possibly by other mechanisms. We asked whether the anti-inflammatory role of TRPV1 changes with age. First, we studied the effect of AMG517, a selective and potent TRPV1 antagonist, on aseptic, lipopolysaccharide (LPS)-induced SIRS in young (12 wk) mice. In agreement with previous studies, AMG517 increased LPS-induced mortality in the young. We then studied the effects of TRPV1 antagonism (AMG517 or genetic deletion of TRPV1) on SIRS in middle-aged...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578496</comments>
            <pubDate>Wed, 11 Jan 2012 16:01:04 +0100</pubDate>
            <guid isPermaLink="false">5578496</guid>        </item>
        <item>
            <title>Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.</title>
            <link>http://www.medworm.com/index.php?rid=5578495&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22214766%26dopt%3DAbstract</link>
            <description>Authors: Wang X, Sistrunk C, Miliani de Marval PL, Kim Y, Rodriguez-Puebla ML
    Abstract
    We have previously demonstrated that ras-mediated skin tumorigenesis depends on signaling pathways that act preferentially through cyclin D1 and D2. Interestingly, the expression of cyclin D3 inhibits skin tumor development, an observation that conflicts with the oncogenic role of D-type cyclins in the mouse epidermis. Here, we show that simultaneous up- and down-regulation of particular members of the D-type cyclin family is a valuable approach to reduce skin tumorigenesis. We developed the K5D3/cyclin D1 (-/-) compound mouse which overexpresses cyclin D3 but lacks expression of cyclin D1 in the skin. Similar to K5D3 transgenic mice, keratinocytes from K5D3/cyclin D1 (-/-) compound mice show a s...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578495</comments>
            <pubDate>Wed, 11 Jan 2012 16:00:53 +0100</pubDate>
            <guid isPermaLink="false">5578495</guid>        </item>
        <item>
            <title>Brain and muscle ARNT-like protein BMAL1 regulates ROS homeostasis and senescence: A possible link to hypoxia-inducible factor-mediated pathway.</title>
            <link>http://www.medworm.com/index.php?rid=5578494&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22223094%26dopt%3DAbstract</link>
            <description>Authors: Razorenova OV
    Abstract
    Comment on: Khapre RV, et al. Cell Cycle 2011; 10:4162-9.
    PMID: 22223094 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578494</comments>
            <pubDate>Wed, 11 Jan 2012 16:00:42 +0100</pubDate>
            <guid isPermaLink="false">5578494</guid>        </item>
        <item>
            <title>Fine-tuning of the intracellular canonical Notch signaling pathway.</title>
            <link>http://www.medworm.com/index.php?rid=5578493&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22223095%26dopt%3DAbstract</link>
            <description>Authors: Borggrefe T, Liefke R
    Abstract
    Notch signaling plays a pivotal role in the regulation of many fundamental cellular processes, such as proliferation, stem cell maintenance and differentiation during embryonic and adult development. At the molecular level, ligand binding induces the proteolytic cleavage of the Notch receptor. The intracellular domain of Notch translocates subsequently into the nucleus, associates with the central transcription factor RBP-J and activates transcription. Although, this pathway is remarkably short, with no second messenger involved, it regulates expression of more than hundred target genes in a tissue-specific manner. This review summarizes recent studies on transcriptional and chromatin control mechanisms, which set the stage for specific expre...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578493</comments>
            <pubDate>Wed, 11 Jan 2012 16:00:32 +0100</pubDate>
            <guid isPermaLink="false">5578493</guid>        </item>
        <item>
            <title>Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: A novel therapeutic modality.</title>
            <link>http://www.medworm.com/index.php?rid=5578492&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22223138%26dopt%3DAbstract</link>
            <description>Authors: Yemelyanov A, Bhalla P, Yang X, Ugolkov A, Iwadate K, Karseladze A, Budunova I
    Abstract
    Androgen (AR) and glucocorticoid (GR) receptor signaling play opposing roles in prostate tumorigenesis: in prostate, AR acts as an oncogene, and GR is a tumor suppressor. Recently, we found that non-steroidal phyto-chemical Compound A (CpdA) is AR/GR modulator acting as anti-inflammatory anti-androgen. CpdA inhibits AR and prevents GR transactivation while enhancing GR transrepression. GR and AR are controlled by proteasomal degradation. We found that prolonged exposure of LNCaP, LNCaP-GR, DU145 and PC3 prostate carcinoma (PCa) cells to proteasome inhibitor Bortezomib (BZ) caused AR degradation and GR accumulation. BZ enhanced CpdA ability to inhibit AR and to augment GR transrepression...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5578492</comments>
            <pubDate>Wed, 11 Jan 2012 16:00:22 +0100</pubDate>
            <guid isPermaLink="false">5578492</guid>        </item>
        <item>
            <title>Many defects make a cyst.</title>
            <link>http://www.medworm.com/index.php?rid=5550352&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22193033%26dopt%3DAbstract</link>
            <description>Authors: Shah JV
    Abstract
    Comment on: Delaval B, et al. Cell Cycle 2011; 10:3964-72.
    PMID: 22193033 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5550352</comments>
            <pubDate>Thu, 29 Dec 2011 23:30:59 +0100</pubDate>
            <guid isPermaLink="false">5550352</guid>        </item>
        <item>
            <title>The riddle of intergenic disease-associated loci.</title>
            <link>http://www.medworm.com/index.php?rid=5550351&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22193034%26dopt%3DAbstract</link>
            <description>Authors: Manolio TA, Chanock SJ
    Abstract
    Comment on: Glinskii AB, et al. Cell Cycle 2011; 10:3571-97.
    PMID: 22193034 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5550351</comments>
            <pubDate>Thu, 29 Dec 2011 23:30:48 +0100</pubDate>
            <guid isPermaLink="false">5550351</guid>        </item>
        <item>
            <title>Yeast as a platform to uncover ceramide-induced ancient cell death routines.</title>
            <link>http://www.medworm.com/index.php?rid=5550350&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22193035%26dopt%3DAbstract</link>
            <description>Authors: Costa V, Ludovico P
    Abstract
    Comment on: Carmona-Gutierrez D, et al. Cell Cycle 2011; 10:3973-8.
    PMID: 22193035 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5550350</comments>
            <pubDate>Thu, 29 Dec 2011 23:30:36 +0100</pubDate>
            <guid isPermaLink="false">5550350</guid>        </item>
        <item>
            <title>Metabolic compartments in tumor tissue: Implications for therapy.</title>
            <link>http://www.medworm.com/index.php?rid=5550349&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22193036%26dopt%3DAbstract</link>
            <description>Authors: Harris AL
    Abstract
    Comment on: Diana Whitaker-Menezes D, et al. Cell Cycle 2011; 10:4047-64.
    PMID: 22193036 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5550349</comments>
            <pubDate>Thu, 29 Dec 2011 23:30:25 +0100</pubDate>
            <guid isPermaLink="false">5550349</guid>        </item>
        <item>
            <title>Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes.</title>
            <link>http://www.medworm.com/index.php?rid=5550348&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22193044%26dopt%3DAbstract</link>
            <description>Authors: Rossetti S, Esposito J, Corlazzoli F, Gergorski A, Sacchi N
    Abstract
    Most physiological and biological processes are regulated by endogenous circadian rhythms under the control of both a master clock, which acts systemically and individual cellular clocks, which act at the single cell level. The cellular clock is based on a network of core clock genes, which drive the circadian expression of non-clock genes involved in many cellular processes. Circadian deregulation of gene expression has emerged to be as important as deregulation of estrogen signaling in breast tumorigenesis. Whether there is a mutual deregulation of circadian and hormone signaling is the question that we address in this study. Here we show that, upon entrainment by serum shock, cultured human mammary epi...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5550348</comments>
            <pubDate>Thu, 29 Dec 2011 23:30:14 +0100</pubDate>
            <guid isPermaLink="false">5550348</guid>        </item>
        <item>
            <title>&quot;Cell Cycle&quot;[ta]; +114 new citations</title>
            <link>http://www.medworm.com/index.php?rid=5535153&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fcmd%3DSearch%26db%3Dpubmed%26term%3D%28%2520%28%2522Cell%2520Cycle%2522%255Bta%255D%29%2520AND%2520%25222011%252F11%252F18%252018.48%2522%255BEDAT%255D%253A%25222011%252F12%252F23%252018.36%2522%255BEDAT%255D%29</link>
            <description>114 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

&quot;Cell Cycle&quot;[ta]
These pubmed results were generated on 2011/12/23PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources. (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5535153</comments>
            <pubDate>Fri, 23 Dec 2011 23:36:01 +0100</pubDate>
            <guid isPermaLink="false">5535153</guid>        </item>
        <item>
            <title>Energy transfer in &quot;parasitic&quot; cancer metabolism: Mitochondria are the powerhouse and Achilles' heel of tumor cells.</title>
            <link>http://www.medworm.com/index.php?rid=5379981&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033146%26dopt%3DAbstract</link>
            <description>Energy transfer in &quot;parasitic&quot; cancer metabolism: Mitochondria are the powerhouse and Achilles' heel of tumor cells.
    Cell Cycle. 2011 Dec 15;10(24)
    Authors: Martinez-Outschoorn UE, Pestell RG, Howell A, Nagajyothi F, Machado FS, Tanowitz HB, Sotgia F, Lisanti MP
    Abstract
    It is now widely recognized that the tumor microenvironment promotes cancer cell growth and metastasis via changes in cytokine secretion and extracellular matrix remodeling. However, the role of tumor stromal cells in providing energy for epithelial cancer cell growth is a newly emerging paradigm. For example, we and others have recently proposed that tumor growth and metastasis is related to an energy imbalance. Host cells produce energy-rich nutrients via catabolism (through autophagy, mitophagy, and aero...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379981</comments>
            <pubDate>Sun, 06 Nov 2011 20:29:57 +0100</pubDate>
            <guid isPermaLink="false">5379981</guid>        </item>
        <item>
            <title>Conversion from senescent cells to pluripotent cells by modulating expression of Alu retroelements.</title>
            <link>http://www.medworm.com/index.php?rid=5380015&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024914%26dopt%3DAbstract</link>
            <description>Authors: Iwasaki O, Corcoran CJ, Noma KI
    Abstract
    Comment on: Wang J, et al. Cell Cycle 2011; 10:3016-30.
    PMID: 22024914 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380015</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380015</guid>        </item>
        <item>
            <title>The importance of mitochondrial fusion in aging.</title>
            <link>http://www.medworm.com/index.php?rid=5380014&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024915%26dopt%3DAbstract</link>
            <description>Authors: Mazzoni C, Falcone C
    Abstract
    Comment on: Scheckhuber CQ, et al. Cell Cycle 2011; 10:3105-10.
    PMID: 22024915 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380014</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380014</guid>        </item>
        <item>
            <title>Neuroendocrine cells: Potential cells of origin for small cell lung carcinoma.</title>
            <link>http://www.medworm.com/index.php?rid=5380013&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024916%26dopt%3DAbstract</link>
            <description>Authors: Cheng CY, Nikitin AY
    Abstract
    Comment on: Park KS, et al. Cell Cycle 2011; 10:2806-15.
    PMID: 22024916 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380013</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380013</guid>        </item>
        <item>
            <title>SUMO bridges Elg1 and SUMO interactors.</title>
            <link>http://www.medworm.com/index.php?rid=5380012&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024917%26dopt%3DAbstract</link>
            <description>Authors: Hang LE, Zhao X
    Abstract
    Comment on: Parnas O, et al. Cell Cycle 2011; 10:2894-903.
    PMID: 22024917 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380012</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380012</guid>        </item>
        <item>
            <title>Do neuroendocrine cells come up large in small cell lung cancer?</title>
            <link>http://www.medworm.com/index.php?rid=5380011&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024918%26dopt%3DAbstract</link>
            <description>Authors: Goldstein AS, Huang J
    Abstract
    Comment on: Park K, et al. Cell Cycle 2011; 10:2140-50.
    PMID: 22024918 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380011</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380011</guid>        </item>
        <item>
            <title>The tumor suppressor p53 induces expression of the pregnancy-supporting human chorionic gonadotropin (hCG) CGB7 gene.</title>
            <link>http://www.medworm.com/index.php?rid=5379984&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22032922%26dopt%3DAbstract</link>
            <description>Authors: Sohr S, Engeland K
    Abstract
    Successful pregnancy requires a functionally normal blastocyst encountering a receptive maternal endometrium. Interestingly, the cell cycle regulator and tumor suppressor p53 has been reported to support reproduction in mice by regulating the expression of the leukemia inhibitory factor gene in the maternal endometrium. However, in humans the hormonal system orchestrating successful pregnancy is considerably different from rodents. Particularly, the primate-specific dimeric glycoprotein hormone human chorionic gonadotropin (hCG) is essential for blastocyst implantation and maintenance of early human pregnancy. Here we provide evidence that p53 selectively induces expression of the hCGbeta7 (CGB7) gene. None of the other CGB genes was found to be...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379984</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379984</guid>        </item>
        <item>
            <title>CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination.</title>
            <link>http://www.medworm.com/index.php?rid=5379983&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22032989%26dopt%3DAbstract</link>
            <description>This study identifies CSA and CSB as the key elements of a regulatory mechanism that equilibrate beneficial and detrimental effects of p53 activity upon cellular stress. The deregulation of p53, in absence of either of the CS proteins, can potentially explain the early onset degeneration of tissues and organs observed in CS patients.
    PMID: 22032989 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379983</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379983</guid>        </item>
        <item>
            <title>Glis1, a unique pro-reprogramming factor, may facilitate clinical applications of iPSC technology.</title>
            <link>http://www.medworm.com/index.php?rid=5379982&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033139%26dopt%3DAbstract</link>
            <description>Authors: Maekawa M, Yamanaka S
    Abstract
    Comment on: Maekawa M, et al. Nature 2011; 474:225-9.
    PMID: 22033139 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379982</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379982</guid>        </item>
        <item>
            <title>GSK-3 turns p53 deadly.</title>
            <link>http://www.medworm.com/index.php?rid=5379980&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033176%26dopt%3DAbstract</link>
            <description>Authors: Charvet C, Maurer U
    Abstract
    Comment on: Charvet C, et al. Mol Cell 2011; 42:584-96.
    PMID: 22033176 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379980</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379980</guid>        </item>
        <item>
            <title>The odd couple: Innate-like B cells and the chemokine scavenger D6.</title>
            <link>http://www.medworm.com/index.php?rid=5379979&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033177%26dopt%3DAbstract</link>
            <description>Authors: Hansell CA, Nibbs RJ
    Abstract
    Comment on: Hansell CA, et al. Blood 2011; 117:5413-24.
    PMID: 22033177 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379979</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379979</guid>        </item>
        <item>
            <title>Targeting RSK2 in myeloid leukemia: Right for FLT3 but wrong for BCR-ABL.</title>
            <link>http://www.medworm.com/index.php?rid=5379978&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033178%26dopt%3DAbstract</link>
            <description>Authors: Lee BH, Kang S
    Abstract
    Comment on: Elf S, et al. Blood 2011; 117:6885-94.
    PMID: 22033178 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379978</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379978</guid>        </item>
        <item>
            <title>Rif1/2 and Tel1 function in separate pathways during replicative senescence.</title>
            <link>http://www.medworm.com/index.php?rid=5379977&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033189%26dopt%3DAbstract</link>
            <description>Authors: Chang M, Rothstein R
    PMID: 22033189 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379977</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379977</guid>        </item>
        <item>
            <title>Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification.</title>
            <link>http://www.medworm.com/index.php?rid=5379976&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033190%26dopt%3DAbstract</link>
            <description>Authors: Eguiara A, Holgado O, Beloqui I, Abalde L, Sanchez Y, Callol C, Martin AG
    Abstract
    The cancer stem cell is defined by its capacity to self-renew, the potential to differentiate into all cells of the tumor and the ability to proliferate and drive the expansion of the tumor. Thus, targeting these cells may provide novel anti-cancer treatment strategies. Breast cancer stem cells have been isolated according to surface marker expression, ability to efflux fluorescent dyes, increased activity of aldehyde dehydrogenase or the capacity to form spheres in non-adherent culture conditions. In order to test novel drugs directed towards modulating self-renewal of cancer stem cells, rapid, easy and inexpensive assays must be developed. Using 2 days-post-fertilization (dpf) zebrafish em...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379976</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379976</guid>        </item>
        <item>
            <title>Mammalian cryptochromes impinge on cell cycle progression in a circadian clock-independent manner.</title>
            <link>http://www.medworm.com/index.php?rid=5379975&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033214%26dopt%3DAbstract</link>
            <description>Authors: Destici E, Oklejewicz M, Saito S, van der Horst GT
    Abstract
    By gating cell cycle progression to specific times of the day, the intracellular circadian clock is thought to reduce the exposure of replicating cells to potentially hazardous environmental and endogenous genotoxic compounds. Although core clock gene defects that eradicate circadian rhythmicity can cause an altered in vivo genotoxic stress response and aberrant proliferation rate, it remains to be determined to what extent these cell cycle related phenotypes are due to a cell-autonomous lack of circadian oscillations. We investigated the DNA damage sensitivity and proliferative capacity of cultured primary Cry1 (‑/- ) (|) Cry2 (‑/-) fibroblasts. Contrasting previous in vivo studies, we show that the absence...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379975</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379975</guid>        </item>
        <item>
            <title>Cdk1: A kinase with changing substrate specificity.</title>
            <link>http://www.medworm.com/index.php?rid=5379974&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033215%26dopt%3DAbstract</link>
            <description>Authors: Kõivomägi M, Loog M
    Abstract
    Comment on: Kõivomägi M, et al. Mol Cell 2011; 42:610-23.
    PMID: 22033215 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379974</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379974</guid>        </item>
        <item>
            <title>Acetylation is indispensable for p53 antiviral activity.</title>
            <link>http://www.medworm.com/index.php?rid=5379973&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033337%26dopt%3DAbstract</link>
            <description>Authors: Muñoz-Fontela C, González D, Marcos-Villar L, Campagna M, Gallego P, González-Santamaría J, Herranz D, Gu W, Serrano M, Aaronson SA, Rivas C
    Abstract
    Tumor suppressor p53 is known to be a direct transcriptional target of type I interferons (IFNs), contributing to virus-induced apoptosis, and in turn activating itself the interferon pathway. Acetylation, among many other post-translational modifications of p53, is thought to exert a crucial role regulating p53 activity. Here, we examined the contribution of this modification on the antiviral activity mediated by p53. Our results show that virus infection induces p53 acetylation at lysine 379, and that this modification is absolutely required for p53-dependent transcriptional transactivation of both, pro-apoptotic and IF...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379973</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379973</guid>        </item>
        <item>
            <title>Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation.</title>
            <link>http://www.medworm.com/index.php?rid=5379972&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22033440%26dopt%3DAbstract</link>
            <description>Authors: Ricke RM, van Deursen JM
    Abstract
    High expression of the mitotic kinase Bub1 is associated with a variety of human cancers and correlates with poor clinical prognosis, but whether Bub1 alone can drive tumorigenesis was unknown. We provided conclusive evidence that Bub1 has oncogenic properties by generating transgenic mice that overexpress Bub1 in a wide variety of tissues, resulting in aneuploidization. Consistently, Bub1 transgenic mice developed various kinds of spontaneous tumors as well as accelerated Myc-induced lymphomagenesis. While the mitotic checkpoint was robust in Bub1 overexpressing cells, misaligned and lagging chromosomes were observed. These defects originated from increased Aurora B activity and could be suppressed by inhibition of Aurora B. Taken togethe...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379972</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379972</guid>        </item>
        <item>
            <title>A few good genes: Simple, biologically motivated signatures for cancer prognosis.</title>
            <link>http://www.medworm.com/index.php?rid=5379971&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037208%26dopt%3DAbstract</link>
            <description>Authors: Gentles AJ, Alizadeh AA
    Abstract
    Comment on: Alizadeh AA, et al. Blood. 2011; 118:1350-8.
    PMID: 22037208 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379971</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379971</guid>        </item>
        <item>
            <title>Systems biology of epistasis: Shedding light on genetic interaction network &quot;hubs&quot;</title>
            <link>http://www.medworm.com/index.php?rid=5379970&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037209%26dopt%3DAbstract</link>
            <description>Systems biology of epistasis: Shedding light on genetic interaction network &quot;hubs&quot;
    Cell Cycle. 2011 Nov 1;10(21)
    Authors: Papp B, Pál C
    Abstract
    Comment on: Szappanos B, et al. Nat Genet 2011; 43:656-62.
    PMID: 22037209 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379970</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379970</guid>        </item>
        <item>
            <title>Polypyrimidine tract-binding protein regulates the cell cycle through IRES-dependent translation of CDK11p58 in mouse embryonic stem cells.</title>
            <link>http://www.medworm.com/index.php?rid=5379969&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037210%26dopt%3DAbstract</link>
            <description>Authors: Ohno S, Shibayama M, Sato M, Tokunaga A, Yoshida N
    Abstract
    Polypyrimidine tract-binding protein (PTB/PTBP1/hnRNP I) is a member of the heterogeneous nuclear ribonucleoprotein family that binds specifically to pyrimidine-rich sequences of RNAs. Although PTB is a multifunctional protein involved in RNA processing and internal ribosome entry site (IRES)-dependent translation, the role of PTB in early mouse development is unclear. Ptb knockout mice exhibit embryonic lethality shortly after implantation and Ptb-/- embryonic stem (ES) cells have a severe proliferation defect that includes a prolonged G2/M phase. The present study shows that PTB promotes M phase progression by the direct repression of CDK11p58 IRES activity in ES cells. The protein expression and IRES activity o...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379969</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379969</guid>        </item>
        <item>
            <title>Closed MAD2 (C-MAD2) is selectively incorporated into the mitotic checkpoint complex (MCC).</title>
            <link>http://www.medworm.com/index.php?rid=5379968&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037211%26dopt%3DAbstract</link>
            <description>Authors: Tipton AR, Tipton M, Yen T, Liu ST
    Abstract
    The mitotic checkpoint is a specialized signal transduction pathway that monitors kinetochore-microtubule attachment to achieve faithful chromosome segregation. MAD2 is an evolutionarily conserved mitotic checkpoint protein that exists in open (O) and closed (C) conformations. The increase of intracellular C-MAD2 level during mitosis, through OC-MAD2 conversion as catalyzed by unattached kinetochores, is a critical signaling event for the mitotic checkpoint. However, it remains controversial whether MAD2 is an integral component of the effector of the mitotic checkpoint---the Mitotic Checkpoint Complex (MCC). We show here that endogenous human MCC is assembled by first forming a BUBR1:BUB3:CDC20 complex in G2 and then selectiv...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379968</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379968</guid>        </item>
        <item>
            <title>Morgana and Melusin: Two fairies chaperoning signal transduction.</title>
            <link>http://www.medworm.com/index.php?rid=5379967&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037254%26dopt%3DAbstract</link>
            <description>Authors: Ferretti R, Sbroggiò M, Di Savino A, Fusella F, Bertero A, Michowski W, Tarone G, Brancaccio M
    Abstract
    Chaperones and scaffold proteins are key elements involved in controlling the assembly of molecular complexes required for coordinated signal transduction. Here we describe morgana and melusin, two phylogenetically conserved chaperones that cooperate with Hsp90 and regulate signal transduction in important physiopathological processes. While morgana is ubiquitously expressed, melusin expression is restricted to striated muscles. Despite high sequence homology, the two chaperones have distinct functions. Morgana controls genomic stability by regulating the centrosome cycle via ROCKII kinase. Melusin, however, organizes ERK signal transduction in cardiomyocytes and regula...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379967</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379967</guid>        </item>
        <item>
            <title>The role of eIF5A in protein synthesis.</title>
            <link>http://www.medworm.com/index.php?rid=5379966&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037286%26dopt%3DAbstract</link>
            <description>Authors: Henderson A, Hershey JW
    Abstract
    Comment on: Henderson A, et al. Proc Natl Acad Sci USA 2011; 108:6415-9.
    PMID: 22037286 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379966</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379966</guid>        </item>
        <item>
            <title>Activation of DNA damage response pathways in human mesenchymal stem cells exposed to cisplatin or gamma-irradiation.</title>
            <link>http://www.medworm.com/index.php?rid=5379965&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22037398%26dopt%3DAbstract</link>
            <description>Authors: Prendergast AM, Cruet-Hennequart S, Shaw G, Barry FP, Carty MP
    Abstract
    DNA damaging agents are widely used in treatment of hematogical malignancies and solid tumors. While effects on hematopoietic stem cells have been characterized, less is known about the DNA damage response in human mesenchymal stem cells (hMSCs) in the bone marrow stroma, progenitors of osteoblasts, chondrocytes and adipocytes. To elucidate the response of undifferentiated hMSCs to gamma-irradiation and cisplatin, key DNA damage responses have been characterised in hMSCs from normal adult donors. Cisplatin and gamma-irradiation activated the DNA damage response in hMSCs, including induction of p53 and p21, and activation of PI3 kinase-related protein kinase (PIKK)-dependent phosphorylation of histone H...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379965</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379965</guid>        </item>
        <item>
            <title>Caveolin-1 promotes pancreatic cancer cell differentiation and restores membranous E-cadherin via suppression of the epithelial-mesenchymal transition.</title>
            <link>http://www.medworm.com/index.php?rid=5379964&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22041584%26dopt%3DAbstract</link>
            <description>Authors: Salem AF, Bonuccelli G, Bevilacqua G, Arafat HA, Pestell RG, Sotgia F, Lisanti MP
    Abstract
    Pancreatic cancer is one of the deadliest cancers due to early rapid metastasis and chemoresistance. Recently, epithelial to mesenchymal transition (EMT) was shown to play a key role in the pathogenesis of pancreatic cancer. To understand the role of caveolin-1 (Cav-1) in EMT, we over-expressed Cav-1 in a pancreatic cancer cell line, Panc 10.05, that does not normally express Cav-1. Here, we show that Cav-1 expression in pancreatic cancer cells induces an epithelial phenotype and promotes cell-cell contact, with increased expression of plasma membrane bound E-cadherin and beta-catenin. Mechanistically, Cav-1 induces Snail downregulation and decreased activation of AKT, MAPK and TGF-b...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379964</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379964</guid>        </item>
        <item>
            <title>GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells.</title>
            <link>http://www.medworm.com/index.php?rid=5379963&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22041656%26dopt%3DAbstract</link>
            <description>Authors: Siejka A, Barabutis N, Schally AV
    Abstract
    AMP-activated protein kinase (AMPK) regulates cellular proliferation, growth and metabolism. Targeted activation of AMPK is considered an important therapeutic strategy for cancer treatment. To evaluate the effect of growth hormone-releasing hormone (GHRH) and its antagonist MZ-5-156 on the phosphorylation of AMPK and other related regulatory intracellular proteins we employed human non-small cell lung cancer cell line A549, which expresses GHRH receptors. Treatment of A549 cells with GHRH antagonist decreased cell proliferation and activated AMPK as well as glycogen synthase kinase (GSK)3β. Furthermore, MZ-5-156 inhibited Akt, the mammalian target of rapamycin (mTOR) and its downstream target eIF4E which controls protein synthes...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379963</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379963</guid>        </item>
        <item>
            <title>DNA ligase III: A spotty presence in eukaryotes, but an essential function where tested.</title>
            <link>http://www.medworm.com/index.php?rid=5379962&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22041657%26dopt%3DAbstract</link>
            <description>Authors: Simsek D, Jasin M
    Abstract
    DNA ligases are crucial for most DNA transactions, including DNA replication, repair, and recombination. Recently, DNA ligase III (Lig3) has been demonstrated to be crucial for cell survival due to its catalytic function in mitochondria. This review summarizes these recent results and reports on a hitherto unappreciated widespread phylogenetic presence of Lig3 in eukaryotes, including in some organisms before the divergence of metazoa. Analysis of these putative Lig3 homologs suggests that many of them are likely to be found in mitochondria and to be critical for mitochondrial function.
    PMID: 22041657 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379962</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379962</guid>        </item>
        <item>
            <title>Regulation of β-adrenergic receptor function: An emphasis on receptor resensitization.</title>
            <link>http://www.medworm.com/index.php?rid=5379961&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22041711%26dopt%3DAbstract</link>
            <description>Authors: Vasudevan NT, Mohan ML, Goswami SK, Naga Prasad SV
    Abstract
    G protein-coupled receptors are the largest family of cell surface receptors regulating multiple cellular processes. β-adrenergic receptor (βAR) is a prototypical member of GPCR family and has been one of the most well studied receptors in determining regulation of receptor function. Agonist activation of βAR leads to conformational change resulting in coupling to G protein generating cAMP as secondary messenger. The activated βAR is phosphorylated resulting in binding of β-arrestin that physically interdicts further G protein coupling leading to receptor desensitization. The phosphorylated βAR is internalized and undergoes resensitization by dephosphorylation mediated by protein phosphatase 2A in the early ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379961</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379961</guid>        </item>
        <item>
            <title>Notch signaling mediates p63-induced quiescence: A new facet of p63/Notch crosstalk.</title>
            <link>http://www.medworm.com/index.php?rid=5379960&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22041817%26dopt%3DAbstract</link>
            <description>Authors: Forster N, Ellisen LW
    Abstract
    Comment on: Kent S, et al. Cell Cycle 2011; 10:3111-8.
    PMID: 22041817 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379960</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379960</guid>        </item>
        <item>
            <title>RNA processing in a tiny transcriptome.</title>
            <link>http://www.medworm.com/index.php?rid=5379959&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22045038%26dopt%3DAbstract</link>
            <description>Authors: Kupsch C, Schmitz-Linneweber C
    Abstract
    Comment on: Lopez Sanchez MIG, et al. Cell Cycle 2011; 10:2904-16.
    PMID: 22045038 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379959</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379959</guid>        </item>
        <item>
            <title>Addition of N-terminal peptide sequences activates the oncogenic and signaling potentials of the catalytic subunit p110α of phosphoinositide 3-kinase.</title>
            <link>http://www.medworm.com/index.php?rid=5379958&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22045127%26dopt%3DAbstract</link>
            <description>Authors: Sun M, Hart JR, Hillmann P, Gymnopoulos M, Vogt PK
    Abstract
    Addition of short (6 to 16 amino acids) peptide sequences to the N-terminus of p110α induces a gain of function. Such sequences include the common Flag, His, and VSV tags as well as random sequences. An N-terminal myristylation signal generally believed to activate p110α by providing a constitutive membrane address is also activating, if myristylation is mutationally abolished. The gain of function seen with N-terminally tagged (NTT) p110α constructs extends to signaling, oncogenic transformation and stimulation of cell growth. The activating effect of N-terminal tags requires a functional Ras-binding domain in p110α. Mutations in that domain (T208D and K227A) abolish the gains of function in oncogenicity and ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379958</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379958</guid>        </item>
        <item>
            <title>Regulating the levels of key factors in cell cycle and DNA repair: New pathways revealed by lamins.</title>
            <link>http://www.medworm.com/index.php?rid=5379957&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22045204%26dopt%3DAbstract</link>
            <description>Authors: Redwood AB, Gonzalez-Suarez I, Gonzalo S
    Abstract
    Spatial and temporal organization of the genome represents an additional step in the regulation of nuclear functions. The nuclear lamina, a polymeric meshwork formed by lamins (A/C and B type) and lamin-associated proteins, plays a key role in the maintenance of genome localization, structure and function. Specifically, mutations in the LMNA gene -encoding lamins A/C- or changes in its expression -either upregulation or silencing- are associated with defects in DNA replication, transcription and repair, as well as alterations in epigenetic modifications of chromatin. These data, together with the fact that defects in A-type lamins are associated with a whole variety of degenerative disorders, premature aging syndromes and c...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379957</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379957</guid>        </item>
        <item>
            <title>mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: A roadmap from energy metabolism to stem cell renewal and aging.</title>
            <link>http://www.medworm.com/index.php?rid=5379956&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22052357%26dopt%3DAbstract</link>
            <description>This article reviews the existing research evidence that the most established mTOR inhibitors can notably decelerate the cellular senescence that is imposed by DNA damage-like responses, which are somewhat equivalent to the responses caused by reprogramming factors. These data suggest that fine-tuning mTOR signaling can impact mitochondrial dynamics to segregate mitochondria that are destined for clearance through autophagy, which results in the loss of mitochondrial function and in the accelerated onset of the glycolytic metabolism that is required to fuel reprogramming. By critically exploring how mTOR-regulated senescence, bioenergetic infrastructure and autophagy can actively drive the reprogramming of somatic cells to pluripotency, we define a metabolic roadmap that may be helpful for...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379956</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379956</guid>        </item>
        <item>
            <title>Caveolin-1: A new therapeutic target in tissue fibrosis and scleroderma?</title>
            <link>http://www.medworm.com/index.php?rid=5379955&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22052358%26dopt%3DAbstract</link>
            <description>Authors: Del Galdo F
    Abstract
    Comment  on: Castello-Cros R, et al. Cell Cycle 2011; 10:2140-50.
    PMID: 22052358 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379955</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379955</guid>        </item>
        <item>
            <title>Outcome of the p53 mediated DNA damage response in neuroblastoma is determined by morphological sub-type and MYCN expression.</title>
            <link>http://www.medworm.com/index.php?rid=5379954&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22052359%26dopt%3DAbstract</link>
            <description>Conclusions: The downstream response to DNA damage in p53 wild-type neuroblastoma cell lines is p53 dependent, and determined both by the morphological sub-type and MYCN expression.
    PMID: 22052359 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379954</comments>
            <pubDate>Tue, 01 Nov 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379954</guid>        </item>
        <item>
            <title>RUNX1 and its understudied role in breast cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5380010&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024923%26dopt%3DAbstract</link>
            <description>Authors: Janes KA
    Abstract
    The transcription factor Runt-related transcription factor 1 (RUNX1) is critical for the earliest steps of hematopoiesis. RUNX1 was originally identified as a gene fusion in acute myeloid leukemia (AML) and thus has garnered heavy attention as a tumor suppressor in hematopoietic malignancies. However, RUNX1 is also strongly expressed in breast epithelia and may be misregulated during tumorigenesis. Here, I discuss our recent work implicating RUNX1 in proliferation control during breast epithelial-acinar morphogenesis. My goal is to place these findings in the context of a handful of other reports, which together argue that RUNX1 could act as a tumor suppressor gene in breast cancer. Testing this hypothesis requires focused in vivo studies, because the maj...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380010</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380010</guid>        </item>
        <item>
            <title>mTOR protein localization is cell cycle regulated.</title>
            <link>http://www.medworm.com/index.php?rid=5380009&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024924%26dopt%3DAbstract</link>
            <description>Authors: Rosner M, Hengstschläger M
    PMID: 22024924 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380009</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380009</guid>        </item>
        <item>
            <title>Modulated microtubule dynamics enable Hklp2/Kif15 to assemble bipolar spindles.</title>
            <link>http://www.medworm.com/index.php?rid=5380008&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024925%26dopt%3DAbstract</link>
            <description>Authors: Florian S, Mayer TU
    Abstract
    Activity of the sliding motor Eg5 and coordinated microtubule dynamics are both essential for mitotic spindle pole separation. It is still a matter of controversy if changes in microtubule dynamics can compensate inhibition of Eg5 activity and re-enable bipolarization. Using a consistent live-cell-imaging approach, we show that perturbation of microtubule dynamics can compensate inhibition of Eg5 through a spindle formation process reminiscent of meiosis: In Eg5-inhibited mammalian somatic cells, alteration of microtubule dynamics through depletion of TOGp or low doses of nocodazole induces the formation of multiple acentrosomal spindle poles which pass through an intermediate multipolar state followed by bipolarization. Pole separation depends...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380008</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380008</guid>        </item>
        <item>
            <title>FBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrest.</title>
            <link>http://www.medworm.com/index.php?rid=5380007&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024926%26dopt%3DAbstract</link>
            <description>Authors: Chen BB, Glasser JR, Coon TA, Mallampalli RK
    Abstract
    Mitotic progression is regulated by ubiquitin E3 ligase complexes to carefully orchestrate eukaryotic cell division. Here we show that a relatively new E3 ligase component belonging to the SCF (Skip-Cullin1-F-box protein) E3 ligase family, SCF (FBXL2) , impairs cell proliferation by mediating cyclin D3 polyubiquitination and degradation. Both cyclin D3 and FBXL2 co-localize within the centrosome. FBXL2 overexpression led to G2/M phase arrest in transformed epithelia resulting in appearance of supernumerary centrosomes, tetraploidy, and nuclei where condensed chromosomes are arranged on circular monopolar spindles typical of mitotic arrest.  RNAi mediated knockdown of cyclin D3 recapitulated effects of SCF (FBXL2) expre...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380007</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380007</guid>        </item>
        <item>
            <title>Multiple roles of ELG1 with different interactions determine various cellular processes.</title>
            <link>http://www.medworm.com/index.php?rid=5380006&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024927%26dopt%3DAbstract</link>
            <description>Authors: McCulley J, Myung K
    Abstract
    Comment on: Parnas O, et al. Cell Cycle 2011; 10:2894-903.
    PMID: 22024927 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380006</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380006</guid>        </item>
        <item>
            <title>p21 regulates the cell cycle…or the other way around?</title>
            <link>http://www.medworm.com/index.php?rid=5380005&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024928%26dopt%3DAbstract</link>
            <description>Authors: Speroni J, Gottifredi V
    Abstract
    Comment on: Ciznadija D, et al. Cell Cycle 2011; 10:2714-23.
    PMID: 22024928 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380005</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380005</guid>        </item>
        <item>
            <title>The sweet secrets of p27kip1 regulation and function in cell migration.</title>
            <link>http://www.medworm.com/index.php?rid=5380004&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024929%26dopt%3DAbstract</link>
            <description>Authors: Fearon E
    Abstract
    Comment on: Nagano Y, et al. Cell Cycle 2011; 10:2593-603.
    PMID: 22024929 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380004</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380004</guid>        </item>
        <item>
            <title>New role for Spinophilin in tumor suppression.</title>
            <link>http://www.medworm.com/index.php?rid=5380003&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024930%26dopt%3DAbstract</link>
            <description>Authors: Palmero I
    Abstract
    Comment on: Ferrer I, et al. Cell Cycle 2011; 10:2751-62.
    PMID: 22024930 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380003</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380003</guid>        </item>
        <item>
            <title>Lamins reach out to novel functions in DNA damage repair.</title>
            <link>http://www.medworm.com/index.php?rid=5380002&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024931%26dopt%3DAbstract</link>
            <description>Authors: Brachner A, Foisner R
    Abstract
    Comment on: Redwood AB, et al. Cell Cycle 2011; 10:2550-61.
    PMID: 22024931 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380002</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380002</guid>        </item>
        <item>
            <title>Redundancy in response to DNA damage: The key to protection of genome integrity.</title>
            <link>http://www.medworm.com/index.php?rid=5380001&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22024932%26dopt%3DAbstract</link>
            <description>Authors: Darzynkiewicz Z
    Abstract
    Comment on: Ciznadija D, et al. Cell Cycle 2011; 10:2714-23.
    PMID: 22024932 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380001</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380001</guid>        </item>
        <item>
            <title>Small cell lung cancer: New insights into origins.</title>
            <link>http://www.medworm.com/index.php?rid=5380000&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030465%26dopt%3DAbstract</link>
            <description>Authors: Macpherson D
    Abstract
    Comment on: Park K, et al. Cell Cycle 2011; 10:2806-15.
    PMID: 22030465 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5380000</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5380000</guid>        </item>
        <item>
            <title>Endocrine pancreas development in zebrafish.</title>
            <link>http://www.medworm.com/index.php?rid=5379999&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030554%26dopt%3DAbstract</link>
            <description>Authors: Tehrani Z, Lin S
    Abstract
    Type 1 diabetes results from the autoimmune destruction of insulin-producing pancreatic β cells. Current efforts to cure diabetes are aimed at replenishing damaged cells by generating a new supply of β cells in vitro. The most promising strategy for achieving this goal is to differentiate embryonic stem (ES) cells by sequentially exposing them to signaling molecules that they would normally encounter in vivo. This approach requires a thorough understanding of the temporal sequence of the signaling events underlying pancreatic β-cell induction during embryonic development. The zebrafish system has emerged as a powerful tool in the study of pancreas development. In this review, we provide a temporal summary of pancreas development in zebrafish wi...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379999</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379999</guid>        </item>
        <item>
            <title>Molecular cloning and characterization of Mitogen-activated protein kinase 2 in Toxoplasma gondii.</title>
            <link>http://www.medworm.com/index.php?rid=5379998&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030559%26dopt%3DAbstract</link>
            <description>Authors: Huang H, Ma YF, Bao Y, Lee H, Lisanti MP, Tanowitz HB, Weiss LM
    Abstract
    Toxoplasma gondii is an obligate intracellular protozoan that is both a human and animal pathogen. This Apicomplexan causes significant morbidity and mortality in immune competent and immune compromised hosts. In humans, the most common manifestations of T. gondii infections are chorioretinitis in congenital infection and encephalitis in immune compromised patients such as patients with advanced AIDS. Mitogen-activated protein kinase (MAPK) pathways are major signal transduction systems by which eukaryotic cells convert environmental cues to intracellular events such as proliferation and differentiation. We have identified a T. gondii homologue of the MAPK family that we have called TgMAPK2. Sequence ...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379998</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379998</guid>        </item>
        <item>
            <title>Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition.</title>
            <link>http://www.medworm.com/index.php?rid=5379997&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030621%26dopt%3DAbstract</link>
            <description>Authors: Höglund A, Strömvall K, Li Y, Forshell LP, Nilsson JA
    Abstract
    Myc is a transcription factor frequently found deregulated in human cancer. The Myc-mediated cellular transformation process is associated with fast proliferative cells and inherent genomic instability, giving rise to malignant, invasive neoplasms with poor prognosis for survival. Transcription-independent functions of Myc include stimulation of replication. Excessive Myc expression stimulates a replication-associated DNA damage response that signal via the phosphoinositide 3-kinase (PI3K) related protein kinases (PIKKs) ATM and ATR. These in turn activate the DNA damage transducers Chk1 and Chk2. Here, we show that Myc can stimulate Chek2 transcript indirectly in vitro, as well as in B cells of λ-Myc transg...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379997</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379997</guid>        </item>
        <item>
            <title>Identification and modeling of a phosphatase-like domain in a tRNA 2'-O-ribosyl phosphate transferase Rit1p.</title>
            <link>http://www.medworm.com/index.php?rid=5379996&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030622%26dopt%3DAbstract</link>
            <description>Authors: Czerwoniec A, Bujnicki JM
    Abstract
    Cytoplasmic initiator tRNAs from plants and fungi are excluded from participating in translational elongation by the presence of a unique 2'-phosphoribosyl modification of purine 64, introduced posttranscriptionally by the enzyme Rit1p. Members of the Rit1p family show no obvious similarity to other proteins or domains, there is no structural information available to guide experimental analyses, and the mechanism of action of this enzyme remains a mystery. Using protein fold-recognition we identified a phosphatase-like domain in the C-terminal part of Rit1p. A comparative model of the C-terminal domain was constructed and used to predict the function of conserved residues and to propose the mechanism of action of Rit1p. The model will fac...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379996</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379996</guid>        </item>
        <item>
            <title>Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: A role for HBV-induced HCC.</title>
            <link>http://www.medworm.com/index.php?rid=5379995&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030623%26dopt%3DAbstract</link>
            <description>Authors: Knoll S, Fürst K, Thomas S, Villanueva Baselga S, Stoll A, Schaefer S, Pützer BM
    Abstract
    Chronic hepatitis B virus (HBV) infection is the major risk for hepatocellular carcinomas (HCC). HBV X protein (HBx) and p53 tumor suppressor family interactions may be crucial for HCC induction. We compared p53 and p73 interactions with HBx in normal and HCC tumor cell lines differing in their p53 status. In the latter, HBx was pro-apoptotic, but exhibited opposite effects in non-tumor cells. In these normal cells, p53 and p73 were retained in the cytoplasm. In hepatoma cells, however, HBx led to nuclear translocation of p53 and p73 followed by enhanced transactivation of p53-dependent promoters. The nuclear transfer of p53, but not of p73, was abrogated by protein kinase C inhibit...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379995</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379995</guid>        </item>
        <item>
            <title>Differential epithelium DNA damage response to ATM and DNA-PK pathway inhibition in human prostate tissue culture.</title>
            <link>http://www.medworm.com/index.php?rid=5379994&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030624%26dopt%3DAbstract</link>
            <description>Authors: Zhang Z, Yang Z, Jäämaa S, Liu H, Pellakuru LG, Iwata T, Af Hällström TM, De Marzo AM, Laiho M
    Abstract
    The ability of cells to respond and repair DNA damage is fundamental for the maintenance of genomic integrity. Ex vivo-culturing of surgery-derived human tissues has provided a significant advancement to assess DNA damage response (DDR) in the context of normal cytoarchitecture in a non-proliferating tissue. Here we assess the dependency of prostate epithelium DDR on ATM and DNA-PKcs, the major kinases responsible for damage detection and repair by non-homologous end-joining (NHEJ), respectively. DNA damage was caused by ionizing radiation (IR) and cytotoxic drugs, cultured tissues were treated with ATM and DNA-PK inhibitors, and DDR was assessed by phosphorylation o...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379994</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379994</guid>        </item>
        <item>
            <title>Caveolin-1: Would-be Achilles' heel of tumor microenvironment?</title>
            <link>http://www.medworm.com/index.php?rid=5379993&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030625%26dopt%3DAbstract</link>
            <description>Authors: Furuta S, Ghajar CM, Bissell MJ
    Abstract
    Comment on: Witkiewicz AK, et al. Cell Cycle 2011; 10:1794-809.
    PMID: 22030625 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379993</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379993</guid>        </item>
        <item>
            <title>Targeting JunD: A potential strategy to counteract hormone-refractory prostate cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5379992&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030692%26dopt%3DAbstract</link>
            <description>Authors: Sarkar D, Wang XY, Fisher PB
    Abstract
    Comment on: Zerbini LF, et al. Cell Cycle 2011; 10:2583-91.
    PMID: 22030692 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379992</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379992</guid>        </item>
        <item>
            <title>Prostate cancer: JunD, Gadd45a and Gadd45g as therapeutic targets.</title>
            <link>http://www.medworm.com/index.php?rid=5379991&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030693%26dopt%3DAbstract</link>
            <description>Authors: Liebermann DA, Hoffman B
    Abstract
    Comment on: Zerbini L, et al. Cell Cycle 2011; 10: 2584-92.
    PMID: 22030693 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379991</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379991</guid>        </item>
        <item>
            <title>Generation of a set of conditional analog-sensitive alleles of essential protein kinases in the fission yeast Schizosaccharomyces pombe.</title>
            <link>http://www.medworm.com/index.php?rid=5379990&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22030861%26dopt%3DAbstract</link>
            <description>Authors: Cipak L, Zhang C, Kovacikova I, Rumpf C, Miadokova E, Shokat KM, Gregan J
    Abstract
    The genome of the fission yeast Schizosaccharomyces pombe encodes for 17 protein kinases that are essential for viability. Studies of the essential kinases often require the use of conditional alleles. To inactivate these kinases conditionally, we applied a recently developed chemical-genetic strategy. The mutation of a single residue in the ATP-binding pocket confers sensitivity to small-molecule inhibitors, allowing for specific inactivation of the modified kinase. Using this approach, we constructed conditional analog-sensitive alleles of 13 essential protein kinases in the fission yeast S. pombe.
    PMID: 22030861 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379990</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379990</guid>        </item>
        <item>
            <title>The H2B ubiquitin ligase RNF40 cooperates with SUPT16H to induce dynamic changes in chromatin structure during DNA double-strand break repair.</title>
            <link>http://www.medworm.com/index.php?rid=5379989&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22031019%26dopt%3DAbstract</link>
            <description>Authors: Kari V, Shchebet A, Neumann H, Johnsen SA
    Abstract
    Many anticancer therapies function largely by inducing DNA double-strand breaks (DSBs) or altering the ability of cancer cells to repair them. Proper and timely DNA repair requires dynamic changes in chromatin assembly and disassembly characterized by histone H3 lysine 56 acetylation (H3K56ac) and phosphorylation of the variant histone H2AX (γH2AX). Similarly, histone H2B monoubiquitination (H2Bub1) functions in DNA repair, but its role in controlling dynamic changes in chromatin structure following DSBs and the histone chaperone complexes involved remain unknown. Therefore, we investigated the role of the H2B ubiquitin ligase RNF40 in the DSB response. We show that RNF40 depletion results in sustained H2AX phosphorylatio...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379989</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379989</guid>        </item>
        <item>
            <title>MG132 inhibition of proteasome blocks high-dose UV irradiation-induced apoptosis.</title>
            <link>http://www.medworm.com/index.php?rid=5379988&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22031102%26dopt%3DAbstract</link>
            <description>Authors: Zhang L, Hu JJ, Gong F
    Abstract
    The 26S proteasome, a multicatalytic enzyme complex, is the main intracellular proteolytic system involved in the degradation of ubiquitinated proteins. The ability of proteasome inhibitors to induce apoptosis has been exploited in the recent development of chemotherapeutic agents. Here, we show that inhibition of proteasome by MG132 blocks DNA damage-induced apoptosis. Blockage of apoptosis by MG132 correlates with p53 stabilization and upregulation of p21/WAF1, a p53 transcriptional target. Surprisingly, in the absence of MG132, robust apoptosis induced by a high dose of UV irradiation correlate with rapid p53 degradation. This is in sharp contrast to p53 stabilization when cells were exposed to lower levels of UV irradiation. Our findings...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379988</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379988</guid>        </item>
        <item>
            <title>Translational control by 80S formation and 60S availability: The central role of eIF6, a rate limiting factor in cell cycle progression and tumorigenesis.</title>
            <link>http://www.medworm.com/index.php?rid=5379987&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22031223%26dopt%3DAbstract</link>
            <description>Authors: Brina D, Grosso S, Miluzio A, Biffo S
    Abstract
    Ribosome biogenesis and translation can be simplified as the processes of generating ribosomes and their use for decoding mRNA into a protein. Ribosome biogenesis has been efficiently studied in unicellular organisms like the budding yeast, allowing us a deep and basic knowledge of this process in growing cells. Translation has been modeled in vitro and in unicellular organisms. These studies have given us an important insight on the mechanisms and evolutionarily conserved aspects of ribosome biology. However, we advocate the need of the direct study of these processes in multicellular organisms. Analysis of ribosome biogenesis and translation, in vivo, in Metazoa and mammalian models is emerging and unveils the unexpected con...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379987</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379987</guid>        </item>
        <item>
            <title>Cell cycle phosphorylation of mitotic exit network (MEN) proteins.</title>
            <link>http://www.medworm.com/index.php?rid=5379986&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22031224%26dopt%3DAbstract</link>
            <description>Authors: Jones MH, Keck JM, Wong CC, Xu T, Yates JR, Winey M
    Abstract
    Phosphorylation of proteins is an important mechanism used to regulate most cellular processes. Recently we completed an extensive phosphoproteomic analysis of the core proteins that constitute the Saccharomyces cerevisiae centrosome. Here we present a study of phosphorylation sites found on the mitotic exit network (MEN) proteins, most of which are associated with the cytoplasmic face of the centrosome. We identified 55 sites on Bfa1, Cdc5, Cdc14, and Cdc15. Eight sites lie in cyclin-dependent kinase motifs (Cdk, S/T-P), and 22 sites are completely conserved within fungi. More than half of the sites were found in centrosomes from mitotic cells, possibly in preparation for their roles in mitotic exit. Finally, we...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379986</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379986</guid>        </item>
        <item>
            <title>Acute lymphoblastic leukemia and developmental biology: A crucial interrelationship.</title>
            <link>http://www.medworm.com/index.php?rid=5379985&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D22031225%26dopt%3DAbstract</link>
            <description>Authors: Campos-Sanchez E, Toboso-Navasa A, Romero-Camarero I, Barajas-Diego M, Sanchez-García I, Cobaleda C
    Abstract
    The latest scientific findings in the field of cancer research are redefining our understanding of the molecular and cellular basis of the disease, moving the emphasis towards the study of the mechanisms underlying the alteration of the normal processes of cellular differentiation. The concepts best exemplifying this new vision are those of cancer stem cells and tumoral reprogramming. The study of the biology of acute lymphoblastic leukemias (ALLs) has provided seminal experimental evidences supporting these new points of view. Furthermore, in the case of B-cells, it has been shown that all the stages of their normal development show a tremendous degree of plastici...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5379985</comments>
            <pubDate>Mon, 31 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5379985</guid>        </item>
        <item>
            <title>&quot;Cell Cycle&quot;[ta]; +107 new citations</title>
            <link>http://www.medworm.com/index.php?rid=5297723&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fsites%2Fentrez%3Fcmd%3DSearch%26db%3Dpubmed%26term%3D%28%2520%28%2522Cell%2520Cycle%2522%255Bta%255D%29%2520AND%2520%25222011%252F10%252F04%252002.44%2522%255BEDAT%255D%253A%25222011%252F10%252F09%252006.05%2522%255BEDAT%255D%29</link>
            <description>107 new pubmed citations were retrieved for your search.
Click on the search hyperlink below to display the complete search results:

&quot;Cell Cycle&quot;[ta]
These pubmed results were generated on 2011/10/09PubMed, a service of the National Library of Medicine, includes over 15 million 
citations for biomedical articles back to the 1950's.
These citations are from MEDLINE and additional life science journals. 
PubMed includes links to many sites providing full text articles and other related resources. (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5297723</comments>
            <pubDate>Sun, 09 Oct 2011 10:05:01 +0100</pubDate>
            <guid isPermaLink="false">5297723</guid>        </item>
        <item>
            <title>Senescence-associated microRNAs linked to tumorigenesis.</title>
            <link>http://www.medworm.com/index.php?rid=5281279&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21941082%26dopt%3DAbstract</link>
            <description>Authors: Srikantan S, Gorospe M, Abdelmohsen K
    Abstract
    Comment on: Marasa BS, et al. Aging 2010; 2:333-43.
    PMID: 21941082 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281279</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281279</guid>        </item>
        <item>
            <title>A novel role of hydrogen peroxide in Kaposi sarcoma-associated herpesvirus reactivation.</title>
            <link>http://www.medworm.com/index.php?rid=5281278&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21941083%26dopt%3DAbstract</link>
            <description>Authors: Ye F, Gao SJ
    Abstract
    Reactivation of Kaposi sarcoma-associated herpesvirus (KSHV) from latency for lytic replication plays a pivotal role in the development of KS tumors. However, the physiological factors of KSHV reactivation in KS patients remain undefined. Two recent studies independently discovered that the reactive oxygen species (ROS) H2O2 induces KSHV reactivation in latently infected cells, which can be inhibited by H2O2-specific antioxidants. H2O2 not only directly induces KSHV reactivation but also is involved in spontaneous lytic replication as well as reactivation stimulated by TPA, hypoxia, and cytokines. Furthermore, in a xenograft-based primary effusion lymphoma (PEL) mouse model, in vivo KSHV reactivation is also H2O2-dependent and can be suppressed by ant...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281278</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281278</guid>        </item>
        <item>
            <title>Stuck in a balancing act: Histone methyltransferase activity of KMT1A traps alveolar rhabdomyosarcomas in an undifferentiated state.</title>
            <link>http://www.medworm.com/index.php?rid=5281277&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21941084%26dopt%3DAbstract</link>
            <description>Authors: Macquarrie KL, Tapscott SJ
    Abstract
    Comment on: Lee, et al. Cancer Res 2011; 71:3921-31.
    PMID: 21941084 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281277</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281277</guid>        </item>
        <item>
            <title>Global mitotic phosphorylation of C2H2 zinc finger protein linker peptides.</title>
            <link>http://www.medworm.com/index.php?rid=5281276&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21941085%26dopt%3DAbstract</link>
            <description>In this report, we show the simultaneous phosphorylation and mitotic redistribution of a whole class of modified transcription factors. C2H2 zinc finger proteins (ZFPs) represent the largest group of gene expression regulators in the human genome. Despite their diversity, C2H2 ZFPs display striking conservation of small linker peptides joining their adjacent zinc finger modules. These linkers are critical for DNA binding activity. It has been proposed that conserved phosphorylation of these linker peptides could be a common mechanism for the inactivation of the DNA binding activity of C2H2 ZFPs, during mitosis. Using a novel antibody, raised against the phosphorylated form of the most conserved linker peptide sequence, we are able to visualize the massive and simultaneous mitotic phosphory...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281276</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281276</guid>        </item>
        <item>
            <title>Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.</title>
            <link>http://www.medworm.com/index.php?rid=5281275&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21941086%26dopt%3DAbstract</link>
            <description>Authors: Li H, Lakshmikanth T, Garofalo C, Enge M, Spinnler C, Anichini A, Szekely L, Kärre K, Carbone E, Selivanova G
    Abstract
    Escape of tumor cells from cell-intrinsic barrier mediated by tumor suppressors and cell-extrinsic barrier mediated by the immune system is crucial for tumorigenesis. Growing evidence suggests that reactivation of tumor suppressor function or restoration of anticancer immunity is promising strategy for anticancer therapy due to their high potential to combat cancer. p53, a key tumor suppressor, represses tumorigenesis by eliciting growth arrest, apoptosis or senescence in cancer cells. Here, we unravel that, apart from these cell-autonomous effects, p53 activates the innate immune response against cancer cells. Our results show that pharmacological reacti...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281275</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281275</guid>        </item>
        <item>
            <title>FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor induced apoptosis but not to autophagy.</title>
            <link>http://www.medworm.com/index.php?rid=5281274&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21941087%26dopt%3DAbstract</link>
            <description>Authors: Pandit B, Gartel AL
    Abstract
    Apoptosis has been widely accepted as the primary mechanism of drug-induced cell death. Recently, a second type of cell death pathway has been demonstrated: autophagy, also called programmed type II cell death. Autophagy is a highly regulated process, by which selected components of a cell are degraded. It primarily functions as a cell survival mechanism under stress. However, persistent stress can also promote extensive autophagy leading to cell death. Forkhead box M1 (FoxM1), an oncogenic transcription factor that is abundantly expressed in a wide range of human cancers. Here we evaluated the role of FoxM1 in sensitivity of human cancer cells to proteasome inhibitor-induced apoptosis and autophagy. We found that FoxM1 knockdown sensitized the...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281274</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281274</guid>        </item>
        <item>
            <title>TAp73 is down regulated in oocytes from women of advanced reproductive age.</title>
            <link>http://www.medworm.com/index.php?rid=5281273&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946516%26dopt%3DAbstract</link>
            <description>Authors: Guglielmino MR, Santonocito M, Vento M, Ragusa M, Barbagallo D, Borzì P, Casciano I, Banelli B, Barbieri O, Astigiano S, Scollo P, Romani M, Purrello M, Di Pietro C
    Abstract
    Studies on oocyte transcriptome are important to understand the biological pathways involved in oogenesis, totipotence and early embryonic development. Moreover, genes regulating physiological pathways in gametes could represent potential candidates for reproductive disorders. In addition to oocyte specific transcription factors, also the members of the p53 family could be etiologically involved due to their biological functions. In fact, their role in the control of cell cycle, apoptosis, and germ-line genome stability is well known. Female reproductive aging is one of  the causes of fertility reduc...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281273</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281273</guid>        </item>
        <item>
            <title>&quot;Micromanaging&quot; metabolic syndrome.</title>
            <link>http://www.medworm.com/index.php?rid=5281272&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946517%26dopt%3DAbstract</link>
            <description>&quot;Micromanaging&quot; metabolic syndrome.
    Cell Cycle. 2011 Oct 1;10(19)
    Authors: Ramírez CM, Goedeke L, Fernández-Hernando C
    Abstract
    Metabolic diseases are characterized by the failure of regulatory genes or enzymes to effectively orchestrate specific pathways involved in the control of many biological processes. In addition to the classical regulators of metabolic homeostasis, recent discoveries have shown the remarkable role of small non-coding RNAs (microRNAs) in the post-transcriptional regulation of a number of genes, and their involvement in many pathological states, such as diabetes, atherosclerosis and cancer. Of note is microRNA-33 (miR-33), an intronic microRNA (miRNA) located within the sterol regulatory element-binding protein (SREBP) genes, one of the master regul...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281272</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281272</guid>        </item>
        <item>
            <title>Lamins, guardians of the soma and the genome.</title>
            <link>http://www.medworm.com/index.php?rid=5281271&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946518%26dopt%3DAbstract</link>
            <description>Authors: Freije JM, Pendás AM
    Abstract
    Comment on: Redwood AB, et al. Cell Cycle 2011; 10:2549-60.
    PMID: 21946518 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281271</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281271</guid>        </item>
        <item>
            <title>Novel role of Wip1 in p53-mediated cell homeostasis under a non-stress condition.</title>
            <link>http://www.medworm.com/index.php?rid=5281270&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946519%26dopt%3DAbstract</link>
            <description>Authors: Zhang J, Chen X
    Abstract
    Comment on: Park HK, et al. Cell Cycle 2011; 10:2574-82.
    PMID: 21946519 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281270</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281270</guid>        </item>
        <item>
            <title>Checking before changing: Cell cycle checkpoints inhibit muscle differentiation.</title>
            <link>http://www.medworm.com/index.php?rid=5281269&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946520%26dopt%3DAbstract</link>
            <description>Authors: Wang JY
    Abstract
    Comment on: Simonatto M, et al. Cell Cycle 2011; 10:2355-63.
    PMID: 21946520 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281269</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281269</guid>        </item>
        <item>
            <title>Taccalonolides: A microtubule stabilizer poses a new puzzle with old pieces.</title>
            <link>http://www.medworm.com/index.php?rid=5281268&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946521%26dopt%3DAbstract</link>
            <description>Authors: Sackett DL, Fojo T
    Abstract
    Comment on: Risinger AL, et al. Cell Cycle 2011; 10:2162-71.
    PMID: 21946521 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281268</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281268</guid>        </item>
        <item>
            <title>miR-27a regulation of SCFFbw7 in cell division control and cancer.</title>
            <link>http://www.medworm.com/index.php?rid=5281267&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946522%26dopt%3DAbstract</link>
            <description>Authors: Spruck C
    Abstract
    Comment on: Lerner M, et al. Cell Cycle 2011; 10:2172-83.
    PMID: 21946522 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281267</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281267</guid>        </item>
        <item>
            <title>Autophagic tumor stroma: A biofuel for cancer growth.</title>
            <link>http://www.medworm.com/index.php?rid=5281266&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946523%26dopt%3DAbstract</link>
            <description>Authors: Iozzo RV
    Abstract
    Comment on: Castello-Cros R, et al. Cell Cycle 2011; 10:2021-34.
    PMID: 21946523 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281266</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281266</guid>        </item>
        <item>
            <title>DNA double-strand breaks make bedfellows of ATM and AKT.</title>
            <link>http://www.medworm.com/index.php?rid=5281265&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946524%26dopt%3DAbstract</link>
            <description>Authors: Mukherjee B, Burma S
    Abstract
    Comment on: Fraser M, et al. Cell Cycle 2011; 10:2218-32.
    PMID: 21946524 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281265</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281265</guid>        </item>
        <item>
            <title>MRE11 and ATM AKTivate pro-survival signaling.</title>
            <link>http://www.medworm.com/index.php?rid=5281264&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21946569%26dopt%3DAbstract</link>
            <description>Authors: Golding SE, Valerie K
    Abstract
    Comment on: Fraser, M, et al. Cell Cycle 2011; 10:2218-32.
    PMID: 21946569 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281264</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281264</guid>        </item>
        <item>
            <title>NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.</title>
            <link>http://www.medworm.com/index.php?rid=5281263&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21952639%26dopt%3DAbstract</link>
            <description>Authors: Mori T, Ikeda DD, Fukushima T, Takenoshita S, Kochi H
    Abstract
    In biological networks, a small number of &quot;hub&quot; proteins play critical roles in the network integrity and functions. The cell cycle network orchestrates versatile cellular functions through interactions between many signaling modules, whose defects impair diverse cellular processes, often leading to cancer. However, the network architecture and molecular basis that ensure proper coordination between distinct modules is unclear. Here, we show that the ubiquitin ligase NIRF (also known as UHRF2), which induces G1 arrest, interacts with multiple cell cycle proteins including cyclins (A2, B1, D1 and E1), p53 and pRB, and ubiquitinates cyclins D1 and E1. Consistent with its versatility, a bioinformatic network analy...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281263</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281263</guid>        </item>
        <item>
            <title>Oxidation of Akt2 kinase promotes cell migration and regulates G 1-S transition in the cell cycle.</title>
            <link>http://www.medworm.com/index.php?rid=5281262&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21957489%26dopt%3DAbstract</link>
            <description>Authors: Wani R, Tsang AW, Furdui CM
    Abstract
    Phosphorylation has long been recognized as the key mediator of protein signaling. New modes of signaling regulation are emerging with the development of specific chemical probes and application of high-throughput mass spectrometry technologies. Using biotin-tagged chemical probes for protein oxidation, mass spectrometry and functional assays, our group has recently reported isoform-specific oxidation of Akt2 in response to PDGF signaling. The studies included here investigate the functional consequence of oxidation on Akt2-mediated cell migration and cell cycle. Akt2-KO MEFs transduced with WT and Cys124Ser Akt2 were used as the model system for these studies. The implications of these findings on disease pathology are discussed.
    P...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281262</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281262</guid>        </item>
        <item>
            <title>The ups and downs of p53 regulation in hematopoietic stem cells.</title>
            <link>http://www.medworm.com/index.php?rid=5281261&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21957490%26dopt%3DAbstract</link>
            <description>Authors: Abbas HA, Pant V, Lozano G
    Abstract
    Hematopoietic stem cells provide an indispensible source for replenishing the blood with all its constituents throughout the organism's lifetime. Mice with a compromised hematopoietic stem cell compartment cannot survive. p53, a major tumor suppressor gene, has been implicated in regulation of hematopoiesis. In particular, p53 plays a role in homeostasis by regulating HSC quiescence and self renewal. We recently utilized a hypomorphic p53 ( 515C) allele in conjunction with Mdm2, a negative regulator of p53 to gain insights into the role of p53 in hematopoietic regulation. Our analyses revealed that p53 ( 515C/515C) Mdm2 (-/-) double mutant mice die soon after birth due to hematopoietic failure. Further mechanistic studies revealed that i...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281261</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281261</guid>        </item>
        <item>
            <title>Cyclooxygenase (COX)-1 takes control of adult hippocampal neurogenesis.</title>
            <link>http://www.medworm.com/index.php?rid=5281260&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21957491%26dopt%3DAbstract</link>
            <description>Authors: Pluchino S, Alfaro-Cervello C
    Abstract
    Comment on: Russo I, et al. Cell Cycle 2011; 10:2218-32.
    PMID: 21957491 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281260</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281260</guid>        </item>
        <item>
            <title>Role of caspase 9 in activation of HTLV-1 LTR expression by DNA damaging agents.</title>
            <link>http://www.medworm.com/index.php?rid=5281259&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21957492%26dopt%3DAbstract</link>
            <description>Authors: Abou-Kandil A, Chamias R, Huleihel M, Godbey W, Aboud M
    Abstract
    Abstract Adult T-cell leukemia (ATL) is caused by HTLV-I. The viral Tax oncoprotein plays a central role in initiating the process to ATL. However, after infection HTLV-1 enters into latency, during which virus gene expression is very low, so that the level of Tax is likely insufficient for exerting its oncogenic activities. Therefore only 5% of the infected individuals may develop ATL several decades after infection. It is assumed that the transition from latency to ATL development requires at least a temporary activation of the latent virus in order to elevate Tax to its oncogenic threshold. We have previously found that DNA damaging agents, which usually induce apoptosis, can also activate the viral LTR an...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281259</comments>
            <pubDate>Sat, 01 Oct 2011 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">5281259</guid>        </item>
        <item>
            <title>Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.</title>
            <link>http://www.medworm.com/index.php?rid=5247213&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21926473%26dopt%3DAbstract</link>
            <description>Authors: Erkizan HV, Scher LJ, Gamble SE, Barber-Rotenberg JS, Sajwan KP, Uren A, Toretsky JA
    Abstract
    Ewing tumor is driven by the oncogenic EWS-FLI1 fusion protein that functions as an aberrant transcription factor. The identification of EWS-FLI1 protein partners is essential to enhance its vulnerability as a therapeutic target. We utilized phage display library screening against recombinant EWS-FLI1 protein. We identified 27 unique Ewing sarcoma binding peptides. The cytotoxicity evaluation of these peptides with in EWS-FLI1 containing cell lines yielded one potent peptide called ESAP1 (TMRGKKKRTRAN). ESAP1 binds EWS-FLI1 with 0.202 micromolar affinity as measured in surface plasmon resonance. The minimal interaction region of ESAP1 is characterized and found that the lysine res...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5247213</comments>
            <pubDate>Fri, 23 Sep 2011 18:54:43 +0100</pubDate>
            <guid isPermaLink="false">5247213</guid>        </item>
        <item>
            <title>Elite control of HIV: p21 (waf-1/cip-1) at its best.</title>
            <link>http://www.medworm.com/index.php?rid=5247212&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21926474%26dopt%3DAbstract</link>
            <description>Authors: Yu XG, Lichterfeld M
    Abstract
    Comment on: Chen H, et al. J Clin Invest 2011; 121:1549-60.
    PMID: 21926474 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5247212</comments>
            <pubDate>Fri, 23 Sep 2011 18:54:32 +0100</pubDate>
            <guid isPermaLink="false">5247212</guid>        </item>
        <item>
            <title>LSD1 and pluripotency: A new player in the network.</title>
            <link>http://www.medworm.com/index.php?rid=5247211&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21926475%26dopt%3DAbstract</link>
            <description>Authors: Adamo A, Barrero MJ, Belmonte JC
    Abstract
    Comment on: Adamo A, et al. Nat Cell Biol 2011; 13:652-60.
    PMID: 21926475 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5247211</comments>
            <pubDate>Fri, 23 Sep 2011 18:54:21 +0100</pubDate>
            <guid isPermaLink="false">5247211</guid>        </item>
        <item>
            <title>Recognition of centromeric histone variant CenH3s by their chaperones: Structurally conserved or not.</title>
            <link>http://www.medworm.com/index.php?rid=5247210&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21926476%26dopt%3DAbstract</link>
            <description>Authors: Bai Y, Zhou Z, Feng H, Zhou BR
    Abstract
    Comment on: Zhou et al. Nature 2011; 47:234-237, Hu et al. Genes Dev 2011; 25:901-6 and Cho et al. Proc Natl Acad Sci USA 2011; 108:9367-71.
    PMID: 21926476 [PubMed - as supplied by publisher] (Source: Cell Cycle)</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5247210</comments>
            <pubDate>Fri, 23 Sep 2011 18:54:10 +0100</pubDate>
            <guid isPermaLink="false">5247210</guid>        </item>
        <item>
            <title>The Fanconi anemia pathway is downregulated upon macrophage differentiation through two distinct mechanisms.</title>
            <link>http://www.medworm.com/index.php?rid=5247209&amp;cid=s_37760_171_f&amp;fid=37760&amp;url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fentrez%2Fquery.fcgi%3Ftmpl%3DNoSidebarfile%26db%3DPubMed%26cmd%3DRetrieve%26list_uids%3D21926477%26dopt%3DAbstract</link>
            <description>Authors: Lu WT, Lemonidis K, Drayton RM, Nouspikel T
    Abstract
    The Fanconi anaemia (FA) pathway is a DNA-damage inducible pathway critical for genomic stability. FA patients typically display high cancer susceptibility and hypersensitivity to DNA-damaging agents such as cross-linkers and ionizing radiation. A key step in the activation of the FA pathway is monoubiquitination of the FancD2 protein. Here we report that the FA pathway is downregulated by two distinct mechanisms upon differentiation of THP-1 and HL-60 leukaemia cells into macrophages. Firstly, qRT-PCR analysis revealed a transcriptional downregulation of most components of the FA complex, including FancD2. Secondly, DNA damage-induced monoubiquitination of the remaining FancD2 became deficient at various stages of diffe...</description>
            <author>Cell Cycle</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5247209</comments>
            <pubDate>Fri, 23 Sep 2011 18:53:59 +0100</pubDate>
            <guid isPermaLink="false">5247209</guid>        </item>
    </channel>
</rss>

